image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
733ec406f72193988a4883dadbbe8676167970c353bea357e3dde2570cd216ed.png | simple | <table><tr><td>Criterion</td><td>Data extracted</td></tr><tr><td>Country research conducted</td><td>Country</td></tr><tr><td>Study design</td><td>Between-subjects, within-subject, laboratory, field.</td></tr><tr><td>Participant characteristics</td><td>Total sample size; number of male and female participants; mean, med... | <table><tr><td>Criterion</td><td>Data extracted</td></tr><tr><td>Country research conducted</td><td>Country</td></tr><tr><td>Study design</td><td>Between-subjects, within-subject, laboratory, field.</td></tr><tr><td>Participant characteristics</td><td>Total sample size; number of male and female participants; mean, med... | <table><tr><td>Criterion</td><td>Data extracted</td></tr><tr><td>Risk of bias</td><td>Random allocation to conditions, randomisation methods, allocation concealment, blinding (use of a cover story and participants' beliefs about the study aims; whether the researcher was aware of the study aims or condition that had be... |
758dfa3faefc3e970db9a11b329871b1f9783bd5bd3e28125c2a9c30dd8ce4bf.png | complex | <table><tr><td></td><td colspan="2">Intervention Group (n = 39)</td><td colspan="2">Control Group (n = 40)</td></tr><tr><td></td><td>Baseline</td><td>Week 12</td><td>Baseline</td><td>Week 12</td></tr><tr><td>Work-related PA</td><td></td><td></td><td></td><td></td></tr><tr><td>Vigorous PA</td><td>0 (1080)</td><td>0 (180... | <table><tr><td></td><td colspan="2">Intervention Group (n = 39)</td><td>Control Group (n = 40)</td></tr><tr><td></td><td>Baseline</td><td>Week 12</td><td>Baseline</td></tr><tr><td>Work-related PA</td><td></td><td></td><td></td></tr><tr><td>Vigorous PA</td><td>0 (1080)</td><td>0 (1800)</td><td>0 (720)</td></tr><tr><td>M... | <table><tr><td>Control Group (n = 40)</td></tr><tr><td>Week 12</td></tr><tr><td></td></tr><tr><td>0 (540)</td></tr><tr><td>0 (600)</td></tr><tr><td>0 (1650)</td></tr><tr><td>0 (2730)</td></tr><tr><td></td></tr><tr><td>0 (40)</td></tr><tr><td>70 (1680)</td></tr><tr><td>70 (1720)</td></tr><tr><td></td></tr><tr><td>0 (360... |
ce8f450346ee10ca075bd52f96cf9d538ec784cf0db947247d66469fae5f137a.png | complex | <table><tr><td colspan="10"><i>Coefficients<sup>a</sup></i></td></tr><tr><td rowspan="3" colspan="2"> <i>Model</i></td><td colspan="2"><i>Unstandardized Coefficients</i></td><td><i>Standardized Coefficients</i></td><td rowspan="3"><i>t</i></td><td rowspan="3"><i>Sig.</i></td><td colspan="3"><i>Correlations</i></td></tr... | <table><tr><td colspan="3">Coefficientsa</td></tr><tr><td rowspan="3" colspan="2">Model</td><td>Unstandardized Coefficients</td></tr><tr><td>B</td></tr><tr><td></td></tr><tr><td rowspan="7">1</td><td>(Constant)</td><td>1.556</td></tr><tr><td>Age</td><td>-0.003</td></tr><tr><td>Diabetes Mellitus</td><td>0.365</td></tr><... | <table><tr><td colspan="7">Coefficientsa</td></tr><tr><td>Unstandardized Coefficients</td><td>Standardized Coefficients</td><td rowspan="3">t</td><td rowspan="3">Sig.</td><td colspan="3">Correlations</td></tr><tr><td>Std. Error</td><td>Beta</td><td>Zero-order</td><td>Partial</td><td>Part</td></tr><tr><td colspan="2"></... |
6d5ba9cddf0798b1dd7e8d9df1835180269b4af06fbd4258c0b826da1f268573.png | complex | <table><tr><td>CoW structure</td><td colspan="3">Computation</td><td colspan="3">Measurement [43]</td></tr><tr><td></td><td>L. ICA</td><td>R. ICA</td><td>BA</td><td>L. ICA</td><td>R. ICA</td><td>BA</td></tr><tr><td>Type 1</td><td>4.81</td><td>4.85</td><td>2.36</td><td>5.07</td><td>5.18</td><td>2.75</td></tr><tr><td>Typ... | <table><tr><td>CoW structure</td><td colspan="3">Computation</td><td colspan="3">Measurement [43]</td></tr><tr><td></td><td>L. ICA</td><td>R. ICA</td><td>BA</td><td>L. ICA</td><td>R. ICA</td><td>BA</td></tr><tr><td>Type 1</td><td>4.81</td><td>4.85</td><td>2.36</td><td>5.07</td><td>5.18</td><td>2.75</td></tr><tr><td>Typ... | <table><tr><td>CoW structure</td><td colspan="3">Computation</td><td colspan="3">Measurement [43]</td></tr><tr><td></td><td>L. ICA</td><td>R. ICA</td><td>BA</td><td>L. ICA</td><td>R. ICA</td><td>BA</td></tr><tr><td>Type 3</td><td>4.80</td><td>5.70</td><td>1.49</td><td>5.28</td><td>5.91</td><td>1.50</td></tr></table> |
fcbdb366b904fc9e2622cab052c386ebc045df91f9741e4bb4461c23d02383a9.png | simple | <table><tr><td>Demographics and clinical characteristics</td><td><i>n</i> (%)</td></tr><tr><td>Age (mean ± SD)</td><td>55.4 ± 17.3</td></tr><tr><td>Male</td><td>131 (76.6)</td></tr><tr><td>Medical use before admission</td><td> </td></tr><tr><td> NSAIDs</td><td>43 (25.1)</td></tr><tr><td> PPIs ≤ 2 weeks<... | <table><tr><td>Demographics and clinical characteristics</td><td>n (%)</td></tr><tr><td>Age (mean ± SD)</td><td>55.4 ± 17.3</td></tr><tr><td>Male</td><td>131 (76.6)</td></tr><tr><td>Medical use before admission</td><td></td></tr><tr><td>NSAIDs</td><td>43 (25.1)</td></tr><tr><td>PPIs ≤ 2 weeks</td><td>28 (16.4)</td></tr... | <table><tr><td>Preendoscopic PPIs use</td><td></td></tr><tr><td>High-dose, intravenous</td><td>133 (77.8)</td></tr><tr><td>Low-dose, intravenous</td><td>8 (4.6)</td></tr><tr><td>Oral</td><td>3 (1.8)</td></tr><tr><td>None</td><td>27 (15.8)</td></tr><tr><td>Hemodynamic instability at admission (heart rate > 100 beats per... |
672d04e1dd9594b581c5a1deb432e3258c34f15b16b196b50038e339eb70c9a1.png | complex | <table><tr><td rowspan="2">Cerebral structure</td><td rowspan="2">Embryonic day</td><td colspan="4">Genotype/normalised volume (mm<sup>3</sup> × 10<sup>−2</sup>)</td></tr><tr><td><i>Gldc</i><sup>+/+</sup></td><td><i>Gldc</i><sup>GT1/+</sup></td><td><i>Gldc</i><sup>GT2/+</sup></td><td><i>Gldc</i><sup>GT1/GT2<... | <table><tr><td rowspan="2">Cerebral structure</td><td rowspan="2">Embryonic day</td><td colspan="4">Genotype/normalised volume (mm3 × 10−2)</td></tr><tr><td>Gldc+/+</td><td>GldcGT1/+</td><td>GldcGT2/+</td><td>GldcGT1/GT2</td></tr><tr><td>Mesencephalic vesicle</td><td>16.518.5</td><td>30 ± 515 ± 2*</td><td>34 ± 413 ± 1*... | <table><tr><td>Fourth ventricle</td><td>16.518.5</td><td>14 ± 27 ± 1*</td><td>12 ± 15 ± 1*</td><td>14 ± 24 ± 1*</td><td>10 ± 16 ± 1*</td></tr><tr><td>Fourth ventricle choroid plexus</td><td>16.518.5</td><td>95 ± 110 ± 1</td><td>10 ± 18 ± 1</td><td>11 ± 19 ± 4</td><td>80 ± 110 ± 1</td></tr><tr><td>Cerebellum</td><td>16.... |
2f93e4eb9df2791dffb86a94afd894edb9f8c44edbc2593e4c9c37991d134e72.png | simple | <table><tr><td> </td><td>With Hashimoto’s</td><td>Without Hashimoto’s</td><td>P value</td></tr><tr><td>Number of patients</td><td>653</td><td>5456</td><td> </td></tr><tr><td>Age (years)</td><td>44.4±11.9</td><td>46.3±12.3</td><td>0.077</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td></tr... | <table><tr><td></td><td>With Hashimoto’s</td><td>Without Hashimoto’s</td><td>P value</td></tr><tr><td>Number of patients</td><td>653</td><td>5456</td><td></td></tr></table> | <table><tr><td></td><td>With Hashimoto’s</td><td>Without Hashimoto’s</td><td>P value</td></tr><tr><td>Age (years)</td><td>44.4±11.9</td><td>46.3±12.3</td><td>0.077</td></tr><tr><td>Gender</td><td></td><td></td><td></td></tr><tr><td>Male</td><td>56</td><td>1482</td><td>0.001</td></tr><tr><td>Female</td><td>597</td><td>3... |
be8b8611f3f0c4e5716c1129c9f524e691b6d196c302c6d0953909e043566053.png | complex | <table><tr><td rowspan="3">Entry</td><td colspan="4">PA (<i>n</i> = 30)</td><td rowspan="2" colspan="2">Non-PA (<i>n</i> = 18)</td></tr><tr><td colspan="2">U-PA (<i>n</i> = 13)</td><td colspan="2">B-PA (<i>n</i> = 17)</td></tr><tr><td>Combined</td><td>Single</td><td>Combined</td><td>Single</td><td>Combined</td><td>Sing... | <table><tr><td>Entry</td><td colspan="4">PA (n = 30)</td><td colspan="2">Non-PA (n = 18)</td></tr></table> | <table><tr><td rowspan="2">Entry</td><td colspan="2">U-PA (n = 13)</td><td colspan="2">B-PA (n = 17)</td><td colspan="2">Non-PA (n = 18)</td></tr><tr><td>Combined</td><td>Single</td><td>Combined</td><td>Single</td><td>Combined</td><td>Single</td></tr><tr><td rowspan="2">PAC 30 min/PAC 0 min</td><td>3.3</td><td>1.8</td>... |
4e24d568e95e9f37f3b5228c6c11e627ee412bbf33e05521725e38633e1e2e6b.png | complex | <table><tr><td></td><td>β coefficient</td><td colspan="2">95% CI</td><td>p</td></tr><tr><td>EBM score</td><td>−0.33</td><td>−0.53</td><td>−0.12</td><td><0.01</td></tr><tr><td>% admissions in urgency</td><td>0.02</td><td>−0.07</td><td>0.10</td><td>0.95</td></tr><tr><td>ward (surgical/medi... | <table><tr><td></td><td>β coefficient</td><td colspan="2">95% CI</td><td>p</td></tr><tr><td>EBM score</td><td>−0.33</td><td>−0.53</td><td>−0.12</td><td><0.01</td></tr><tr><td>% admissions in urgency</td><td>0.02</td><td>−0.07</td><td>0.10</td><td>0.95</td></tr></table> | <table><tr><td></td><td>β coefficient</td><td colspan="2">95% CI</td><td>p</td></tr><tr><td>ward (surgical/medical)</td><td>0.64</td><td>−4.71</td><td>5.99</td><td>0.81</td></tr><tr><td>% appropriateness in admissions</td><td>−0.66</td><td>−0.77</td><td>−0.55</td><td><0.01</td></tr><tr><td>constant</td><td>85.27</td><t... |
9309f6d8dd2045998d94bf9d0efac38301b95742e5d0399edbe941626b0b2666.png | complex | <table><tr><td></td><td colspan="2">Peri-centenarian Female</td><td colspan="2">Controls Female</td><td></td><td colspan="2">Peri-centenarian Male</td><td colspan="2">ControlMale</td><td></td></tr><tr><td>Genotype</td><td colspan="2">N = 180</td><td colspan="2">N = 156</td><td><i>p</i></td><td colspan="2">N = 181</td><... | <table><tr><td></td><td colspan="2">Peri-centenarian Female</td><td colspan="2">Controls Female</td><td></td><td colspan="2">Peri-centenarian Male</td><td colspan="2">ControlMale</td><td></td></tr><tr><td>Genotype</td><td colspan="2">N = 180</td><td colspan="2">N = 156</td><td>p</td><td colspan="2">N = 181</td><td cols... | <table><tr><td></td><td colspan="2">Peri-centenarian Female</td><td colspan="2">Controls Female</td><td></td><td colspan="2">Peri-centenarian Male</td><td colspan="2">ControlMale</td><td></td></tr><tr><td>Genotype</td><td colspan="2">N = 180</td><td colspan="2">N = 156</td><td>p</td><td colspan="2">N = 181</td><td cols... |
450e45bb04fb809565c9f63430d59072b242b1cd877d007c9dacf2955185ecfc.png | complex | <table><tr><td>Outcome measures</td><td colspan="2">AT</td><td colspan="2">TAU</td><td rowspan="3">Unpaired <i>t</i> test</td><td rowspan="3"><i>P</i></td></tr><tr><td></td><td colspan="2">(n = 57)</td><td colspan="2">(n = 57)</td></tr><tr><td></td><td>M</td><td>SD</td><td>M</td><td>SD</td></tr><tr><td>ITAQ (0–22... | <table><tr><td>Outcome measures</td><td colspan="2">AT</td><td colspan="2">TAU</td></tr><tr><td></td><td colspan="2">(n = 57)</td><td colspan="2">(n = 57)</td></tr><tr><td></td><td>M</td><td>SD</td><td>M</td><td>SD</td></tr><tr><td>ITAQ (0–22)a</td><td>9.12</td><td>6.14</td><td>9.33</td><td>3.31</td></tr><tr><td>PANSS<... | <table><tr><td rowspan="3">Unpaired t test</td><td rowspan="3">P</td></tr><tr></tr><tr></tr><tr><td>1.52</td><td>0.20</td></tr><tr><td></td><td></td></tr><tr><td>1.71</td><td>0.18</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td>1.49</td><td>0.... |
ccbb8020fffde6790a280beaf15b005d55f2a917d3c604344c86209462851519.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">IORT, <i>n</i> = 267<sup>a</sup></td><td colspan="2">EB-APBI, <i>n</i> = 206</td><td rowspan="2"><i>p</i> value</td></tr><tr><td><i>N</i>, median</td><td>%,range</td><td><i>N,</i> median</td><td>%, range</td></tr><tr><td colspan="6">Age</td></tr><tr><td> Years</td><td>68<... | <table><tr><td rowspan="2"></td><td colspan="2">IORT, n = 267a</td><td>EB-APBI, n = 206</td></tr><tr><td>N, median</td><td>%,range</td><td>N, median</td></tr><tr><td colspan="4">Age</td></tr><tr><td>Years</td><td>68</td><td>59–90</td><td>67</td></tr><tr><td colspan="4">pT stage</td></tr><tr><td>pTis</td><td>18</td><td>... | <table><tr><td>EB-APBI, n = 206</td><td rowspan="2">p value</td></tr><tr><td>%, range</td></tr><tr><td colspan="2">Age</td></tr><tr><td>59–86</td><td>0.683</td></tr><tr><td colspan="2">pT stage</td></tr><tr><td>13%</td><td>0.068</td></tr><tr><td>7%</td><td></td></tr><tr><td>24%</td><td></td></tr><tr><td>43%</td><td></t... |
a5e23d71b43e52a50214d431cc7ddcbca6906b1ea6f6eb59abf50a4542afe434.png | simple | <table><tr><td></td><td>Hospitalisations withAKI diagnosis (<i>N</i> = 230)(%)</td><td>Hospitalisations without AKI diagnosis (<i>N</i> = 7574)(%)</td><td><i>P</i> Value</td></tr><tr><td>Age (years)</td><td></td><td></td><td>< 0.001</td></tr><tr><td> < 65</td><td>10.9</td><td>31.4</td><td></td></tr><tr><td> 65-74... | <table><tr><td></td><td>Hospitalisations withAKI diagnosis (N = 230)(%)</td><td>Hospitalisations without AKI diagnosis (N = 7574)(%)</td><td>P Value</td></tr><tr><td>Age (years)</td><td></td><td></td><td>< 0.001</td></tr><tr><td>< 65</td><td>10.9</td><td>31.4</td><td></td></tr><tr><td>65-74</td><td>22.2</td><td>29.2</t... | <table><tr><td></td><td>Hospitalisations withAKI diagnosis (N = 230)(%)</td><td>Hospitalisations without AKI diagnosis (N = 7574)(%)</td><td>P Value</td></tr><tr><td>Aminoglycoside nebuliser</td><td>1.3</td><td>0.1</td><td>0.001</td></tr><tr><td>Aminoglycoside injection</td><td>1.3</td><td>0.7</td><td>0.227</td></tr><t... |
4716b6b386fea62fc4414fd3aa6e60030098a316554a03ec23eb505eb559fa8b.png | complex | <table><tr><td colspan="3">Among plants in population</td><td colspan="2">Among populations</td></tr><tr><td>Population</td><td>Range of length</td><td>Average length</td><td>Population pair</td><td>Length</td></tr><tr><td><i>Uss</i></td><td>8-41</td><td>17.33</td><td><i>Uss - Spa</i></td><td>24</td></tr><tr><td><i>Spa... | <table><tr><td colspan="3">Among plants in population</td><td>Among populations</td></tr><tr><td>Population</td><td>Range of length</td><td>Average length</td><td>Population pair</td></tr><tr><td>Uss</td><td>8-41</td><td>17.33</td><td>Uss - Spa</td></tr><tr><td>Spa</td><td>9-30</td><td>22.57</td><td>Uss - Dgor</td></tr... | <table><tr><td>Among populations</td></tr><tr><td>Length</td></tr><tr><td>24</td></tr><tr><td>22</td></tr><tr><td>33</td></tr><tr><td>50</td></tr><tr><td>25</td></tr><tr><td>19</td></tr><tr><td>35</td></tr><tr><td>24</td></tr><tr><td>27</td></tr><tr><td></td></tr><tr><td>28.78</td></tr></table> |
98716be544d9a2f760b841856ed8bfca121956bf8b985ccbf560a05b52a90bd4.png | simple | <table><tr><td></td><td>Normal range</td><td>ED admission</td><td>ICU admission</td></tr><tr><td>HR, bpm</td><td>—</td><td>143</td><td>117</td></tr><tr><td>MAP, mmHg</td><td>—</td><td>65</td><td>77</td></tr><tr><td>PaO2/FiO2</td><td>—</td><td>72,7</td><td>120</td></tr><tr><td>Body temperature, °C... | <table><tr><td></td><td>Normal range</td><td>ED admission</td><td>ICU admission</td></tr><tr><td>HR, bpm</td><td>—</td><td>143</td><td>117</td></tr><tr><td>MAP, mmHg</td><td>—</td><td>65</td><td>77</td></tr></table> | <table><tr><td></td><td>Normal range</td><td>ED admission</td><td>ICU admission</td></tr><tr><td>PaO2/FiO2</td><td>—</td><td>72,7</td><td>120</td></tr><tr><td>Body temperature, °C</td><td>—</td><td>38.1</td><td>37.9</td></tr><tr><td>Lactate, mmol/L</td><td>0.5–1.6</td><td>3.4</td><td>1.4</td></tr><tr><td>Creatinine, mg... |
59865f4098f720027ec00e1248bf8c4d3cfca18ada29be80929da175c5c1fda3.png | complex | <table><tr><td></td><td>Factor</td><td>Odds ratio (95 % confidence interval)</td><td><i>p</i>-value</td></tr><tr><td rowspan="2">Time period</td><td>Pre-intervention</td><td>Reference</td><td></td></tr><tr><td>Post-intervention</td><td>1.543 (0.956–2.491)</td><td>0.074</td></tr><tr><td rowspan="2">Monthly trend</... | <table><tr><td></td><td>Factor</td><td>Odds ratio (95 % confidence interval)</td><td>p-value</td></tr><tr><td rowspan="2">Time period</td><td>Pre-intervention</td><td>Reference</td><td></td></tr><tr><td>Post-intervention</td><td>1.543 (0.956–2.491)</td><td>0.074</td></tr><tr><td rowspan="2">Monthly trend</td><td>Pre-in... | <table><tr><td>Total outpatient attendance</td><td>Per 1,000</td><td>0.919 (0.883–0.956)</td><td><0.001</td></tr></table> |
42c15157f75bbf6aaee9878e3868e852f1c581d4078eb11b5e11447e0d1769f5.png | complex | <table><tr><td></td><td colspan="5">% G<sub>2</sub>/M cells</td></tr><tr><td>Time (hr)</td><td>ABZ (nM)</td><td>A2058</td><td>A375</td><td>H1530</td><td>H446</td></tr><tr><td>0</td><td>0</td><td>10.6</td><td>4.7</td><td>4.3</td><td>0.9</td></tr><tr><td>12</td><td>100</td><td>10.0</td><td>13.1</td><td>3.0</td><td>5.2</t... | <table><tr><td></td><td colspan="5">% G2/M cells</td></tr><tr><td>Time (hr)</td><td>ABZ (nM)</td><td>A2058</td><td>A375</td><td>H1530</td><td>H446</td></tr><tr><td>0</td><td>0</td><td>10.6</td><td>4.7</td><td>4.3</td><td>0.9</td></tr><tr><td>12</td><td>100</td><td>10.0</td><td>13.1</td><td>3.0</td><td>5.2</td></tr><tr>... | <table><tr><td>2</td><td>000</td><td>32.3</td><td>.1</td><td>6.3</td><td>71.4</td></tr></table> |
af9922ebe448f0a79b2859d7bb48119dc14bededff5d4a7b61348d72e60d1b91.png | simple | <table><tr><td>Year</td><td>2011</td><td>2010</td><td>2009</td><td>2008</td><td>2007</td><td>2006</td></tr><tr><td>Number of police road stops</td><td>26</td><td>26</td><td>26</td><td>26</td><td>24</td><td>20</td></tr><tr><td>Median number of drivers</td><td>425</td><td>294.5</td><td>300</td><td>323.1</td><td>236.9</td... | <table><tr><td>Year</td><td>2011</td><td>2010</td><td>2009</td><td>2008</td><td>2007</td><td>2006</td></tr><tr><td>Number of police road stops</td><td>26</td><td>26</td><td>26</td><td>26</td><td>24</td><td>20</td></tr><tr><td>Median number of drivers</td><td>425</td><td>294.5</td><td>300</td><td>323.1</td><td>236.9</td... | <table><tr><td>Overtime hours (> 8h) (%)</td><td>42.8</td><td>43.4</td><td>20.9</td><td>28.7</td><td>52.2</td><td>49.9*</td></tr><tr><td>Illicit drug use (% yes)</td><td>8.1</td><td>8.5</td><td>5.8</td><td>4.8</td><td>5.5</td><td>4.1</td></tr><tr><td>Alcohol (% yes)</td><td>23</td><td>30.9</td><td>24.2</td><td>30.3</td... |
506f01105486baed0cb2bcc0d41da5f61ed876703dcb76899fd2b69f381be3dc.png | simple | <table><tr><td>Microorganism Isolated</td><td>Total No. 241 (100)</td></tr><tr><td><i>Pseudomonas aeruginosa</i></td><td>51 (21.16)</td></tr><tr><td><sup>a</sup>MDR <i>Pseudomonas aeruginosa</i></td><td>16 (6.64)</td></tr><tr><td>Methicillin susceptible <i>Staphylococcus aureus</i></td><td>11 (4.56)</td></tr><tr><td>Me... | <table><tr><td>Microorganism Isolated</td><td>Total No. 241 (100)</td></tr><tr><td>Pseudomonas aeruginosa</td><td>51 (21.16)</td></tr><tr><td>aMDR Pseudomonas aeruginosa</td><td>16 (6.64)</td></tr><tr><td>Methicillin susceptible Staphylococcus aureus</td><td>11 (4.56)</td></tr><tr><td>Methicillin resistant Staphylococc... | <table><tr><td>Candida spp</td><td>15 (6.22)</td></tr><tr><td>Virus</td><td>25 (10.37)</td></tr><tr><td>Coronavirus</td><td>1 (0.41)</td></tr><tr><td>Metapneumovirus</td><td>4 (1.65)</td></tr><tr><td>Rhinovirus</td><td>10 (4.14)</td></tr><tr><td>Influenza A</td><td>3 (1.24)</td></tr><tr><td>Influenza B</td><td>2 (0.82)... |
16f8212b8dfa47a144f7a188addc274fd97e628f8de004482c988c548915bdfa.png | complex | <table><tr><td rowspan="2">Maintenance Time (ms)</td><td colspan="2">Rise Time (ms)</td></tr><tr><td>Doped LC</td><td>VA LC</td></tr><tr><td>3</td><td>4.72</td><td>193</td></tr><tr><td>5</td><td>6.96</td><td>115</td></tr><tr><td>10</td><td>–</td><td>108</td></tr></table> | <table><tr><td rowspan="2">Maintenance Time (ms)</td><td colspan="2">Rise Time (ms)</td></tr><tr><td>Doped LC</td><td>VA LC</td></tr><tr><td>3</td><td>4.72</td><td>193</td></tr><tr><td>5</td><td>6.96</td><td>115</td></tr></table> | <table><tr><td>10</td><td>–</td><td>108</td></tr></table> |
4b96b6115f141e90bc866f1329527aa32900f45ce4eefa0dbd1d1b8053f0fbba.png | simple | <table><tr><td>#</td><td>Misincorporation</td><td>Untemplated</td><td>Sequence 5′-GCAUGGGCCC ... -3′</td></tr><tr><td>24</td><td></td><td>+C</td><td>AUGC <underline>C</underline> AUGC AUGC UUGC N<sub>0-3</sub></td></tr><tr><td>20</td><td></td><td>+CC</td><td>AUGC <underline>CC</underline> AUGC AUGC UUGC N<s... | <table><tr><td>#</td></tr><tr><td>24</td></tr><tr><td>20</td></tr><tr><td>2</td></tr><tr><td>38</td></tr><tr><td>14</td></tr><tr><td>4</td></tr><tr><td>1</td></tr><tr><td>1</td></tr></table> | <table><tr><td>Misincorporation</td><td>Untemplated</td><td>Sequence 5′-GCAUGGGCCC ... -3′</td></tr><tr><td></td><td>+C</td><td>AUGC C AUGC AUGC UUGC N0-3</td></tr><tr><td></td><td>+CC</td><td>AUGC CC AUGC AUGC UUGC N0-3</td></tr><tr><td>G→C</td><td>+C</td><td>AUCC C AUGC AUGC UUGC N0-3</td></tr><tr><td>G→C</td><td></t... |
859e81529eb2362e8b04cb779aa5bbd6a64edeb6adc81ec82dee612b48cfef08.png | complex | <table><tr><td>Site</td><td colspan="2">Eligible visits</td><td colspan="3">BMD testing</td><td colspan="3">Initiation of any osteoporosis medication</td><td colspan="3">Initiation of any nutritional supplements (calcium, vitamin D)</td></tr><tr><td></td><td>Median (IQR)</td><td>Total</td><td>Median (IQR)</td><td>Total... | <table><tr><td>Site</td><td colspan="2">Eligible visits</td><td colspan="3">BMD testing</td><td colspan="3">Initiation of any osteoporosis medication</td><td colspan="3">Initiation of any nutritional supplements (calcium, vitamin D)</td></tr><tr><td></td><td>Median (IQR)</td><td>Total</td><td>Median (IQR)</td><td>Total... | <table><tr><td>Site</td><td colspan="2">Eligible visits</td><td colspan="3">BMD testing</td><td colspan="3">Initiation of any osteoporosis medication</td><td colspan="3">Initiation of any nutritional supplements (calcium, vitamin D)</td></tr><tr><td></td><td>Median (IQR)</td><td>Total</td><td>Median (IQR)</td><td>Total... |
a5fbc8a91561efa4d42a5f231a321151bee78e4a45c9d8800acbbd0cce10813d.png | complex | <table><tr><td>Model</td><td>BC (0.94 × 10<sup>−5</sup>/m)a</td><td>PM<sub>2.5</sub> (1.58 μg/m<sup>3</sup>)a</td><td>NO<sub>2</sub> (8.4 μg/m<sup>3</sup>)a</td><td>NO (13.2 μg/m<sup>3</sup>)a</td></tr><tr><td colspan="5">Hospitalization</td></tr><tr><td> Model 1: unadjusted single pollutant</... | <table><tr><td>Model</td><td>BC (0.94 × 10−5/m)a</td><td>PM2.5 (1.58 μg/m3)a</td><td>NO2 (8.4 μg/m3)a</td><td>NO (13.2 μg/m3)a</td></tr><tr><td colspan="5">Hospitalization</td></tr><tr><td>Model 1: unadjusted single pollutant</td><td>1.04 (1.03–1.06)</td><td>1.03 (1.01–1.05)</td><td>1.02 (1.00–1.04)</td><td>0.99 (0.97–... | <table><tr><td> comorbidity, SES</td><td>(1.00–1.03)</td><td>8–1.02)</td><td>(0.95–0.99)</td><td>4–0.98)</td></tr><tr><td>Model 3: + two other pollutantsb</td><td>1.03 (1.01–1.05)</td><td>1.02 (1.00–1.05)</td><td>0.96 (0.94–0.98)</td><td>0.95 (0.92–0.97)</td></tr><tr><td colspan="5">Mortality</td></tr><tr><td>Model 1: ... |
15266687e9007f107d0da92a024b82f9a929aaf1f681ad6d80b00f639fdbb30b.png | complex | <table><tr><td> </td><td colspan="3">Chi-square tests</td></tr><tr><td> </td><td>Value</td><td>df</td><td>Asymp. Sig. (2-sided)</td></tr><tr><td>Pearson chi-square</td><td>.036<sup>a</sup></td><td>3</td><td>.998</td></tr><tr><td>Likelihood ratio</td><td>.036</td><td>3</td><td>.998</td></tr><tr><td>Fisher's exact test</... | <table><tr><td></td><td colspan="3">Chi-square tests</td></tr><tr><td></td><td>Value</td><td>df</td><td>Asymp. Sig. (2-sided)</td></tr><tr><td>Pearson chi-square</td><td>.036a</td><td>3</td><td>.998</td></tr><tr><td>Likelihood ratio</td><td>.036</td><td>3</td><td>.998</td></tr><tr><td>Fisher's exact test</td><td>.074</... | <table><tr><td></td><td colspan="3">Chi-square tests</td></tr><tr><td></td><td>Value</td><td>df</td><td>Asymp. Sig. (2-sided)</td></tr><tr><td>by-linear</td><td>4c</td><td>1</td><td>952</td></tr><tr><td>Association</td><td></td><td></td><td></td></tr><tr><td>N of valid cases</td><td>288</td><td></td><td></td></tr></tab... |
22e7c015a19439e570097fb51ebfc489270c031246fc57a9bb1a7b81cd4fbdb1.png | complex | <table><tr><td></td><td></td><td colspan="5">3 months</td><td colspan="5">6 months</td></tr><tr><td></td><td></td><td colspan="2">Intervention <i>n</i> = 152–155</td><td colspan="2">Control <i>n</i> = 157–159</td><td></td><td colspan="2">Intervention <i>n</i> = 124–127</td><td colspan="2">Control <i>n... | <table><tr><td></td><td></td><td colspan="5">3 months</td><td colspan="5">6 months</td></tr><tr><td></td><td></td><td colspan="2">Intervention n = 152–155</td><td colspan="2">Control n = 157–159</td><td></td><td colspan="2">Intervention n = 124–127</td><td colspan="2">Control n = 133–141</td><td></td></tr><tr><td></td>... | <table><tr><td></td><td></td><td colspan="5">3 months</td><td colspan="5">6 months</td></tr><tr><td></td><td></td><td colspan="2">Intervention n = 152–155</td><td colspan="2">Control n = 157–159</td><td></td><td colspan="2">Intervention n = 124–127</td><td colspan="2">Control n = 133–141</td><td></td></tr><tr><td></td>... |
10616f366c44a55521f5ae3156c14f1c7ee450435a764583fd1df1131fc833ad.png | simple | <table><tr><td>State</td><td>Description</td><td>Probability*</td></tr><tr><td>Normal</td><td>No abnormality</td><td>0.78</td></tr><tr><td>Adenoma <10 mm</td><td>Individual has adenoma that is <10 mm in diameter</td><td>0.1668</td></tr><tr><td>Adenoma ≥10 mm</td><td>Individual has adenoma that is ≥10 ... | <table><tr><td>State</td><td>Description</td><td>Probability*</td></tr><tr><td>Normal</td><td>No abnormality</td><td>0.78</td></tr><tr><td>Adenoma <10 mm</td><td>Individual has adenoma that is <10 mm in diameter</td><td>0.1668</td></tr><tr><td>Adenoma ≥10 mm</td><td>Individual has adenoma that is ≥10 mm in diameter</td... | <table><tr><td>CRC Dukes’ B</td><td>Individual has developed CRC and is at Dukes stage B</td><td>0.0016</td></tr><tr><td>Treatment Dukes’ B</td><td>Individual with Dukes stage B has been diagnosed and will not take part in any further screening</td><td>0</td></tr><tr><td>CRC Dukes’ C</td><td>Individual has developed CR... |
9f2cb63a237890b5518cc2b4613091d492db0959505b0888d9959268c66022e1.png | complex | <table><tr><td rowspan="2">Factors (Number)</td><td colspan="3">Univariate model</td><td colspan="3">Multivariate model #1</td><td colspan="3">Multivariate model #2</td></tr><tr><td>HR</td><td>95% CI</td><td><i>P</i></td><td>HR</td><td>95% CI</td><td><i>P</i></td><td>HR</td><td>95% CI</td><td><i>P</i></td></tr><tr><td>... | <table><tr><td rowspan="2">Factors (Number)</td><td colspan="3">Univariate model</td><td colspan="3">Multivariate model #1</td><td colspan="3">Multivariate model #2</td></tr><tr><td>HR</td><td>95% CI</td><td>P</td><td>HR</td><td>95% CI</td><td>P</td><td>HR</td><td>95% CI</td><td>P</td></tr><tr><td>Age (years)</td><td>1... | <table><tr><td rowspan="2">Factors (Number)</td><td colspan="3">Univariate model</td><td colspan="3">Multivariate model #1</td><td colspan="3">Multivariate model #2</td></tr><tr><td>HR</td><td>95% CI</td><td>P</td><td>HR</td><td>95% CI</td><td>P</td><td>HR</td><td>95% CI</td><td>P</td></tr><tr><td colspan="10">Patholog... |
b12d6588348b99e473a7cfeb7f2c64c2f47b26c645f303208a422f0d268ae46d.png | simple | <table><tr><td></td><td>Peak (1999)</td><td>Crash (2000)</td><td>Peak (2002)</td><td>Crash (2003)</td><td>Peak (2005)</td><td>Crash (2006)</td></tr><tr><td>Peak (1999)</td><td></td><td>0.07000</td><td>0.02667*</td><td>0.01333*</td><td>0.00333*</td><td>0.00333*</td></tr><tr><td>Crash (2000)</td><td>0.0002</td><td></td><... | <table><tr><td></td><td>Peak (1999)</td><td>Crash (2000)</td><td>Peak (2002)</td><td>Crash (2003)</td><td>Peak (2005)</td><td>Crash (2006)</td></tr><tr><td>Peak (1999)</td><td></td><td>0.07000</td><td>0.02667*</td><td>0.01333*</td><td>0.00333*</td><td>0.00333*</td></tr><tr><td>Crash (2000)</td><td>0.0002</td><td></td><... | <table><tr><td>Crash (2006)</td><td>0.0104</td><td>0.0090</td><td>0.0083</td><td>0.0049</td><td>0.0102</td></tr></table> |
78a35d93939abc602621a6604b9f2fdab65f37c69cb3532a7d8c3fe7ab7f140e.png | complex | <table><tr><td rowspan="2">Characteristic</td><td>Intervention arm</td><td>Control arm</td></tr><tr><td>N = 609</td><td>N = 667</td></tr><tr><td>Children’s characteristics</td><td> </td><td> </td></tr><tr><td>Female sex, n (%)</td><td>329 (54.0)</td><td>336 (50.4)</td></tr><tr><td>Mean age, months (SD)</td><td>30... | <table><tr><td rowspan="2">Characteristic</td><td>Intervention arm</td><td>Control arm</td></tr><tr><td>N = 609</td><td>N = 667</td></tr><tr><td>Children’s characteristics</td><td></td><td></td></tr><tr><td>Female sex, n (%)</td><td>329 (54.0)</td><td>336 (50.4)</td></tr><tr><td>Mean age, months (SD)</td><td>30.4 (15.9... | <table><tr><td rowspan="2">Characteristic</td><td>Intervention arm</td><td>Control arm</td></tr><tr><td>N = 609</td><td>N = 667</td></tr><tr><td>Religion, n (%)*#</td><td></td><td></td></tr><tr><td>Catholic</td><td>30 (4.9)</td><td>65 (9.8)</td></tr><tr><td>Protestant</td><td>244 (40.1)</td><td>223 (33.5)</td></tr><tr>... |
56f3e5de4abb048a77a141eb33effd49e566e33920cb413e52a771bd5ca57a6f.png | complex | <table><tr><td rowspan="2">Outcome and instrument</td><td rowspan="2">Method</td><td colspan="3">Data collection time</td></tr><tr><td>T0</td><td>T1</td><td>T2</td></tr><tr><td>Degree of integration</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Self-constructed questionnaire</td><td>Mailed questionnaire</td>... | <table><tr><td>Outcome an</td><td></td><td colspan="3">Data collection time</td></tr></table> | <table><tr><td rowspan="2">d instrument</td><td rowspan="2">Method</td><td colspan="3"></td></tr><tr><td>T0</td><td>T1</td><td>T2</td></tr><tr><td>Degree of integration</td><td></td><td></td><td></td><td></td></tr><tr><td>Self-constructed questionnaire</td><td>Mailed questionnaire</td><td>x</td><td></td><td>x</td></tr>... |
cea850ceffb8445c2c1a60e6590bc37dad1bc671fc2777c7be3eb4918a00a77b.png | complex | <table><tr><td> </td><td colspan="3">Fetal cotyledonary tissue</td><td colspan="3">Maternal caruncular tissue</td></tr><tr><td> </td><td> </td><td colspan="2">fdPAG (mg) and [PAG/TP ratio (%)]</td><td> </td><td colspan="2">fdPAG (mg) and [PAG/TP ratio (%)]</td></tr><tr><td>Purification step</td><td>TP (mg)</td><td>RIA-... | <table><tr><td></td><td colspan="3">Fetal cotyledonary tissue</td><td colspan="3">Maternal caruncular tissue</td></tr><tr><td></td><td></td><td colspan="2">fdPAG (mg) and [PAG/TP ratio (%)]</td><td></td><td colspan="2">fdPAG (mg) and [PAG/TP ratio (%)]</td></tr><tr><td>Purification step</td><td>TP (mg)</td><td>RIA-438<... | <table><tr><td>S.</td><td>1.6</td><td>23]</td><td>]</td><td>956.5</td><td>0.06]</td><td>0]</td></tr><tr><td>40-80% A.S.</td><td>2,014.9</td><td>10.59 [0.53]</td><td>0.44 [0.02]</td><td>815.2</td><td>3.95 [0.48]</td><td>0.31 [0.04]</td></tr></table> |
e8ce128f0d3d053a9313dcb3605c31cb67b1b0601ef89b3c0804b7651a1890e0.png | complex | <table><tr><td>Factor</td><td>Bup</td><td>Bup+Dex(3)</td><td>Bup+Dex(5)</td><td>F</td><td><i>P</i> value</td></tr><tr><td colspan="6">Apgar score</td></tr><tr><td> 1min</td><td>9.0(8.0,9.0)</td><td>9.0(8.0,9.0)</td><td>9.0(8.0,9.0)</td><td>0.59</td><td>0.7450</td></tr><tr><td> 5min</td><td>10.0(9.0,10.0)</td><td>10.0(9... | <table><tr><td>Factor</td><td>Bup</td></tr><tr><td colspan="2">Apgar score</td></tr><tr><td>1min</td><td>9.0(8.0,9.0)</td></tr><tr><td>5min</td><td>10.0(9.0,10.0)</td></tr><tr><td>Umbilical oxygen partial pressure(mmHg)</td><td>24.8±10.3</td></tr><tr><td>Umbilical dioxide partial pressure(mmHg)</td><td>41.9±5.1</td></t... | <table><tr><td>Bup+Dex(3)</td><td>Bup+Dex(5)</td><td>F</td><td>P value</td></tr><tr><td colspan="4">Apgar score</td></tr><tr><td>9.0(8.0,9.0)</td><td>9.0(8.0,9.0)</td><td>0.59</td><td>0.7450</td></tr><tr><td>10.0(9.0,10.0)</td><td>10.0(9.5,10.0)</td><td>0.31</td><td>0.8556</td></tr><tr><td>25.7±8.4</td><td>27.6±9.0</td... |
dd22bd6d9263effdb6906d3f866692bf58d2a36576322b6858db6b0c9456970b.png | complex | <table><tr><td>Red light</td><td> </td></tr><tr><td>GO term</td><td><i>P </i>value</td></tr><tr><td>MF: structural constituent of ribosome</td><td>3.95E–29</td></tr><tr><td>CC: ribosome</td><td>9.50E–25</td></tr><tr><td>BP: translation</td><td>1.22E–22</td></tr><tr><td>CC: integral to membrane</td><td... | <table><tr><td>Red light</td></tr><tr><td>GO term</td></tr><tr><td>MF: structural constituent of ribosome</td></tr><tr><td>CC: ribosome</td></tr><tr><td>BP: translation</td></tr><tr><td>CC: integral to membrane</td></tr><tr><td>BP: cell redox homeostasis</td></tr><tr><td>CC: mitochondrion</td></tr><tr><td>MF: glycerone... | <table><tr><td></td></tr><tr><td>P value</td></tr><tr><td>3.95E–29</td></tr><tr><td>9.50E–25</td></tr><tr><td>1.22E–22</td></tr><tr><td>1.19E–06</td></tr><tr><td>1.96E–06</td></tr><tr><td>8.95E–05</td></tr><tr><td>9.31E–05</td></tr><tr><td>A total of 1,000 genes were submitted to the GOBU functional enrichment tool, wh... |
69c9be13ca194694adb29034dc3ab1e00a0f77a037dfecf52a3a0dfd2a81cc42.png | complex | <table><tr><td rowspan="2">INNO-LIA</td><td rowspan="2">p31</td><td rowspan="2">LAg-Avidity EIA</td><td rowspan="2">BED CEIA</td><td></td><td></td><td colspan="6">Decision tree</td></tr><tr><td>n</td><td></td><td>Seroconversion</td><td>Very early</td><td>Early</td><td>Recent</td><td>Long term</td><td>Advanced</td></tr>... | <table><tr><td rowspan="2">INNO-LIA</td><td rowspan="2">p31</td><td rowspan="2">LAg-Avidity EIA</td><td rowspan="2">BED CEIA</td><td></td><td></td><td colspan="6">Decision tree</td></tr><tr><td>n</td><td></td><td>Seroconversion</td><td>Very early</td><td>Early</td><td>Recent</td><td>Long term</td><td>Advanced</td></tr>... | <table><tr><td>Positive</td><td>Long-term</td><td>Recent</td><td>Recent</td><td>56</td><td rowspan="3">Congruent</td><td></td><td></td><td>56</td><td></td><td></td><td></td></tr><tr><td>Positive</td><td>Long-term</td><td>Long-term</td><td>Recent</td><td>74</td><td></td><td></td><td></td><td>71</td><td></td><td>3</td></... |
e81e5d13b327c2f78bf37bc434cbb7552e0992aa10cfaadf7fb397998ac311c8.png | simple | <table><tr><td>Type of health services</td><td>% use</td><td>CHE<sup>a</sup></td><td>Impoverisment<sup>a</sup></td></tr><tr><td>Dental care</td><td>7.0</td><td>1.88 [1.78-1.99]***</td><td>1.88 [1.78-1.99]***</td></tr><tr><td>Inpatient care</td><td>4.2</td><td>3.93 [3.70-4.17]***</td><td>3.24 [2.99-3.53]***</td></tr><tr... | <table><tr><td>Type of health services</td><td>% use</td><td>CHEa</td><td>Impoverismenta</td></tr><tr><td>Dental care</td><td>7.0</td><td>1.88 [1.78-1.99]***</td><td>1.88 [1.78-1.99]***</td></tr><tr><td>Inpatient care</td><td>4.2</td><td>3.93 [3.70-4.17]***</td><td>3.24 [2.99-3.53]***</td></tr><tr><td>Outpatient care</... | <table><tr><td>Traditional medicine</td><td>6.1</td><td>1.82 [1.72-1.92]***</td><td>1.81 [1.67-1.96]***</td></tr><tr><td>Medications or drugs</td><td>42.7</td><td>4.13 [3.97-4.28]***</td><td>3.49 [3.29-3.70]***</td></tr><tr><td>Health care products</td><td>3.5</td><td>1.88 [1.75-2.02]***</td><td>1.76 [1.56-1.95]***</td... |
6314a390106989086de34a4e26d7d118dfc84a01721a4cd9cd08399b56e3244f.png | simple | <table><tr><td>ECLS strategy</td><td>Possible indication(s)</td></tr><tr><td>VV ECMO + atrial septostomy</td><td>Refractory hypoxia and/or pulmonary hypertension on VV ECMO avoiding sternotomy</td></tr><tr><td>VV ECMO + transeptal return to left atrium</td><td>Refractory hypoxia and/or pulmonary hypertension on VV ECMO... | <table><tr><td>ECLS strategy</td><td>Possible indication(s)</td></tr><tr><td>VV ECMO + atrial septostomy</td><td>Refractory hypoxia and/or pulmonary hypertension on VV ECMO avoiding sternotomy</td></tr></table> | <table><tr><td>ECLS strategy</td><td>Possible indication(s)</td></tr><tr><td>VV ECMO + transeptal return to left atrium</td><td>Refractory hypoxia and/or pulmonary hypertension on VV ECMO avoiding sternotomy</td></tr><tr><td>Venoarterial ECMO + transeptal access from left atrium and right atrium</td><td>Refractory left... |
dc2d76e2cae776c6fa88bb00fa3ddc25e253c1fb6d49b44873e3f86f757333ef.png | complex | <table><tr><td></td><td></td><td>VHV</td><td>Health center</td></tr><tr><td colspan="4">MEAN</td></tr><tr><td>Direct cost 
(Kina; Kina 1 = USD 0.48)</td><td></td><td colspan="2">−1.2977*** 
(0.408)</td><td colspan="2"></td></tr><tr><td>Walking distance (km)</td><td></td><td colspan="2">−0.6843**... | <table><tr><td></td><td></td><td>VHV</td><td>Health center</td><td rowspan="2" colspan="2"></td></tr><tr><td colspan="4">MEAN</td></tr><tr><td>Direct cost
(Kina; Kina 1 = USD 0.48)</td><td></td><td colspan="2">−1.2977***
(0.408)</td><td colspan="2"></td></tr><tr><td>Walking distance (km)</td><td></td><td colspan="2">... | <table><tr><td></td><td></td><td>VHV</td><td>Health center</td><td rowspan="17" colspan="2"></td></tr><tr><td>Gender of patient
(female = 0/male = 1)</td><td></td><td>−1.0621**
(0.514)</td><td>−1.8564**
(0.862)</td></tr><tr><td>Age of patient (year)</td><td></td><td>−0.2646
(0.178)</td><td>−0.7626**
(0.311)</td></... |
209843db5f95f4463c97473be8cdc6fa9c24a44939307db2566a960f8d0a4153.png | complex | <table><tr><td rowspan="2">Assemblers</td><td colspan="4">Repeat</td><td colspan="5">Contigs (kb)</td><td rowspan="2"><i>E</i>-size</td><td rowspan="2">Assembly size (kb)</td><td rowspan="2">Genome coverage (%)</td></tr><tr><td>TRC</td><td>NNC</td><td>Rep-size</td><td>Rep-acc</td><td>Num.C</td><td>N90</td><td>Mean</td>... | <table><tr><td rowspan="2">Assemblers</td><td colspan="4">Repeat</td><td colspan="5">Contigs (kb)</td><td rowspan="2">E-size</td><td rowspan="2">Assembly size (kb)</td><td rowspan="2">Genome coverage (%)</td></tr><tr><td>TRC</td><td>NNC</td><td>Rep-size</td><td>Rep-acc</td><td>Num.C</td><td>N90</td><td>Mean</td><td>N50... | <table><tr><td rowspan="2">Assemblers</td><td colspan="4">Repeat</td><td colspan="5">Contigs (kb)</td><td rowspan="2">E-size</td><td rowspan="2">Assembly size (kb)</td><td rowspan="2">Genome coverage (%)</td></tr><tr><td>TRC</td><td>NNC</td><td>Rep-size</td><td>Rep-acc</td><td>Num.C</td><td>N90</td><td>Mean</td><td>N50... |
b285872d7021cd54dd51e78bcf5d243542cc0c9858c13e26c31c4f6babf43bb6.png | complex | <table><tr><td></td><td colspan="2">Regular Menus</td><td colspan="2">Carbohydrate-Controlled Menus</td><td colspan="2">3000 mg Menus</td><td colspan="2">2000 mg Menus</td></tr><tr><td></td><td>Standard (<i>n</i> = 21)</td><td>Standard Range</td><td>Standard (<i>n</i> = 21)</td><td>Standard Range</td><td>Standard (<i>n... | <table><tr><td></td><td colspan="2">Regular Menus</td><td colspan="2">Carbohydrate-Controlled Menus</td><td colspan="2">3000 mg Menus</td><td colspan="2">2000 mg Menus</td></tr></table> | <table><tr><td></td><td>Standard (n = 21)</td><td>Standard Range</td><td>Standard (n = 21)</td><td>Standard Range</td><td>Standard (n = 21)</td><td>Standard Range</td><td>Standard (n = 21)</td><td>Standard Range</td></tr><tr><td>Calories (kcal)</td><td>1673 ± 362</td><td>1296–3007</td><td>1808 ± 175</td><td>1516–2067</... |
4a8b045cb7398c0f06e9fe81a14f93918f41c355ce0182d2c10a58b2416ce036.png | complex | <table><tr><td rowspan="2">Groups</td><td rowspan="2">Standard error</td><td rowspan="2">Mean difference</td><td rowspan="2">Significance (<i>P</i> ≤ 0.05)</td><td colspan="2">95% Confidence interval for mean</td></tr><tr><td>Lower bound</td><td>Upper bound</td></tr><tr><td>Dentistry versus medicine</td><td>0.775... | <table><tr><td rowspan="2">Groups</td><td rowspan="2">Standard error</td><td rowspan="2">Mean difference</td><td rowspan="2">Significance (P ≤ 0.05)</td><td colspan="2">95% Confidence interval for mean</td></tr><tr><td>Lower bound</td><td>Upper bound</td></tr><tr><td>Dentistry versus medicine</td><td>0.775</td><td>−0.5... | <table><tr><td>Dentistry versus arts</td><td>2</td><td>784</td><td>0.005</td><td>.02</td><td>.54</td></tr><tr><td>Dentistry versus computer science</td><td>0.727</td><td>−1.766</td><td>0.015</td><td>−3.19</td><td>−0.34</td></tr></table> |
8e882870259264984787c5b6b20056df079d2238e82594f5dcebc41540fc8daf.png | simple | <table><tr><td>Unique region ID</td><td>VFDB ID</td><td>GIs</td><td>Gene</td><td>Putative functions</td><td>Organisms</td><td>% Identity</td><td>E-value</td></tr><tr><td>C8R1</td><td>VFG1693</td><td>GI 1</td><td><i>int</i></td><td>Prophage P4 integrase</td><td><i>Escherichia coli</i> CFT073</td><td>33</td><td>1.1E-45</... | <table><tr><td>Unique region ID</td><td>VFDB ID</td><td>GIs</td><td>Gene</td><td>Putative functions</td><td>Organisms</td></tr><tr><td>C8R1</td><td>VFG1693</td><td>GI 1</td><td>int</td><td>Prophage P4 integrase</td><td>Escherichia coli CFT073</td></tr><tr><td>C10R1</td><td>VFG0893</td><td>-</td><td>papA_2</td><td>PapA ... | <table><tr><td>% Identity</td><td>E-value</td></tr><tr><td>33</td><td>1.1E-45</td></tr><tr><td>33</td><td>2.1E-16</td></tr><tr><td>30</td><td>1.4E-16</td></tr><tr><td>27</td><td>1.3E-16</td></tr><tr><td>28</td><td>2.3E-19</td></tr><tr><td>33</td><td>6.7E-23</td></tr><tr><td>31</td><td>1.2E-47</td></tr><tr><td>47</td><t... |
5004bf7e3a0486e4a6f7ff93a9c9fbff3489f25fd3a469578cd85e63e65dfd74.png | complex | <table><tr><td>HAART years</td><td>Mean and standard deviation</td><td>Significance</td></tr><tr><td>1–3</td><td>43.4 ± 23.5</td><td rowspan="4">0.000<sup><i>♣</i></sup></td></tr><tr><td>4–6</td><td>29.9 ± 20.1</td></tr><tr><td>7–10</td><td>30.8 ± 15.9</td></tr><tr><td>>11</td>... | <table><tr><td>HAART years</td></tr><tr><td>1–3</td></tr><tr><td>4–6</td></tr><tr><td>7–10</td></tr><tr><td>>11</td></tr><tr><td></td></tr><tr><td>1–3</td></tr><tr><td>4–6</td></tr><tr><td>7–10</td></tr><tr><td>>11</td></tr><tr><td>4–6</td></tr><tr><td>1–3</td></tr><tr><td>7–10</td></tr><tr><td>>11</td></tr><tr><td>7–1... | <table><tr><td>Mean and standard deviation</td><td>Significance</td></tr><tr><td>43.4 ± 23.5</td><td rowspan="4">0.000♣</td></tr><tr><td>29.9 ± 20.1</td></tr><tr><td>30.8 ± 15.9</td></tr><tr><td>23.4 ± 15.5</td></tr><tr><td>Mean and standard deviation</td><td>Significance</td></tr><tr><td></td><td></td></tr><tr><td>13.... |
b2e67e051110cff7f22725f161e1ad83e74953028c9ffdd6f005a2f4a02fe87e.png | complex | <table><tr><td></td><td colspan="2">Photoelectric</td><td colspan="2">Detector with CO Sensor </td></tr><tr><td></td><td>CO Concentration (ppm)</td><td>CO Dose (ppm minute)</td><td>CO Concentration (ppm)</td><td>CO Dose (ppm minute)</td></tr><tr><td rowspan="9">Shortest time of alarm</td><td>576</td><td>30,859</td><td>... | <table><tr><td></td><td colspan="2">Photoelectric</td><td colspan="2">Detector with CO Sensor</td></tr><tr><td></td><td>CO Concentration (ppm)</td><td>CO Dose (ppm minute)</td><td>CO Concentration (ppm)</td><td>CO Dose (ppm minute)</td></tr><tr><td rowspan="9">Shortest time of alarm</td><td>576</td><td>30,859</td><td>2... | <table><tr><td rowspan="9">Mean time of alarm</td><td>664</td><td>37,593</td><td>35</td><td>875</td></tr><tr><td>1453</td><td>63,957</td><td>42</td><td>766</td></tr><tr><td>638</td><td>24,371</td><td>62</td><td>1236</td></tr><tr><td>907</td><td>39,325</td><td>61</td><td>965</td></tr><tr><td>933</td><td>32,547</td><td>3... |
cd43577af05e2315b7c44fb0bf50e456699135df22d47017bdeffc407701ef8f.png | complex | <table><tr><td>Factors</td><td>Weight</td><td>Parameters</td><td>Weight</td></tr><tr><td rowspan="5">1. Environmental background</td><td rowspan="5">0.10</td><td>1.1 elevation</td><td>0.25</td></tr><tr><td>1.2 Slope</td><td>0.07</td></tr><tr><td>1.3 geomorphological types</td><td>0.36</td></tr><tr><td>1.4 accumulated t... | <table><tr><td>Factors</td><td>Weight</td><td>Parameters</td><td>Weight</td></tr><tr><td rowspan="5">1. Environmental background</td><td rowspan="5">0.10</td><td>1.1 elevation</td><td>0.25</td></tr><tr><td>1.2 Slope</td><td>0.07</td></tr><tr><td>1.3 geomorphological types</td><td>0.36</td></tr><tr><td>1.4 accumulated t... | <table><tr><td>Factors</td><td>Weight</td><td>Parameters</td><td>Weight</td></tr><tr><td rowspan="2">2. Water/land resources</td><td rowspan="2">0.37</td><td>2.2 river density</td><td>0.11</td></tr><tr><td>2.3 land-use types</td><td>0.67</td></tr><tr><td rowspan="3">3. Socio-economic development</td><td rowspan="3">0.5... |
d64b689c7661f2e4679c785adfa8b84bbe260f84d0fca80b584cefd9636c0bf1.png | simple | <table><tr><td>Hypothesis</td><td>Cyt <i>b</i></td><td>16S</td><td>Concatenated</td></tr><tr><td>Monophyly of “Mixed Genera” and “<i>Parougia</i>”</td><td>n.a.1</td><td>0.501</td><td>n.a.1</td></tr><tr><td>Monophyly of “Mixed Genera” and “<i>Ophryotrocha</i>”</td><td>0.09... | <table><tr><td>Hypothesis</td><td>Cyt b</td><td>16S</td><td>Concatenated</td></tr></table> | <table><tr><td>Monophyly of “Mixed Genera” and “Parougia”</td><td>n.a.1</td><td>0.501</td><td>n.a.1</td></tr><tr><td>Monophyly of “Mixed Genera” and “Ophryotrocha”</td><td>0.097</td><td>n.a.1</td><td>0.227</td></tr><tr><td>Monophyly of Ophryotrocha</td><td>0.003</td><td>0.010</td><td>0.001</td></tr><tr><td>Monophyly of... |
8e06c374c706fe36c9ac5c7d6f718e8afa06fa54dcf03f855d739481efb2a90b.png | simple | <table><tr><td></td><td>Control (n=10)</td><td>MSG (n=10)</td><td>P value</td><td></td></tr><tr><td>Urine Volume (ml/day)</td><td>26.9 ± 7.2</td><td>51.5 ± 23.6</td><td>< 0.01</td><td></td></tr><tr><td>Urine pH</td><td>6.6 ± 0.6</td><td>8.7 ± 0.4</td><td>< 0.001</td><td></td></tr><tr><td>Sodiu... | <table><tr><td></td><td>Control (n=10)</td><td>MSG (n=10)</td><td>P value</td><td></td></tr><tr><td>Urine Volume (ml/day)</td><td>26.9 ± 7.2</td><td>51.5 ± 23.6</td><td>< 0.01</td><td></td></tr><tr><td>Urine pH</td><td>6.6 ± 0.6</td><td>8.7 ± 0.4</td><td>< 0.001</td><td></td></tr><tr><td>Sodium (mEq/day)</td><td>1.0 ± ... | <table><tr><td></td><td>Control (n=10)</td><td>MSG (n=10)</td><td>P value</td><td></td></tr><tr><td>Calcium (mg/day)</td><td>3.9 ± 1.2</td><td>4.1 ± 1.2</td><td>NS</td><td></td></tr><tr><td>Phosphate (mg/day)</td><td>36 ± 15</td><td>39 ± 5</td><td>NS</td><td></td></tr><tr><td>Citrate (mmol/day)</td><td>0.43 ± 13</td><t... |
ef1575cacd579ac919eb5a89016336dee48f99022426ab8d8aff7a8987b873dc.png | complex | <table><tr><td></td><td>n</td><td>Males</td><td>n</td><td>Females</td></tr><tr><td colspan="5">Height (cm)</td></tr><tr><td> Birth</td><td>981</td><td>48.4(2.7)</td><td>897</td><td>47.9(2.8)</td></tr><tr><td> 3 mo</td><td>834</td><td>58.4(3.1)</td><td>779</td><td>57.4(3.0)</td></tr><tr><td> 6.5 y</td><td>874</td><td>10... | <table><tr><td></td><td>n</td><td>Males</td><td>n</td><td>Females</td></tr><tr><td colspan="5">Height (cm)</td></tr><tr><td>Birth</td><td>981</td><td>48.4(2.7)</td><td>897</td><td>47.9(2.8)</td></tr><tr><td>3 mo</td><td>834</td><td>58.4(3.1)</td><td>779</td><td>57.4(3.0)</td></tr><tr><td>6.5 y</td><td>874</td><td>107.0... | <table><tr><td>3 mo</td><td>834</td><td>14.7(2.1)</td><td>779</td><td>14.2(1.9)</td></tr><tr><td>6.5 y</td><td>874</td><td>13.9(1.4)</td><td>806</td><td>14.0(1.4)</td></tr><tr><td>15 y</td><td>558</td><td>15.6(1.5)</td><td>550</td><td>16.8(2.0)</td></tr><tr><td>Adult</td><td>981</td><td>20.6(3.4)</td><td>897</td><td>20... |
71233a9d76508c8cf280784820db4fa72bcbede01883072f678a81fc9295ca1f.png | simple | <table><tr><td>Strategy</td><td>Country</td><td>Cases</td><td>Tests</td><td>Prevalence (per 10,000)</td><td>CI 95%</td></tr><tr><td>Intensified monitoring in AS positive flocks</td><td>Finland</td><td>0</td><td>36</td><td>0</td><td>0 - 973.9</td></tr><tr><td></td><td>France</td><td>11</td><td>14965</td><td>7.4</td><td>... | <table><tr><td>Strategy</td><td>Country</td><td>Cases</td><td>Tests</td><td>Prevalence (per 10,000)</td><td>CI 95%</td></tr><tr><td>Intensified monitoring in AS positive flocks</td><td>Finland</td><td>0</td><td>36</td><td>0</td><td>0 - 973.9</td></tr><tr><td></td><td>France</td><td>11</td><td>14965</td><td>7.4</td><td>... | <table><tr><td>Strategy</td><td>Country</td><td>Cases</td><td>Tests</td><td>Prevalence (per 10,000)</td><td>CI 95%</td></tr><tr><td></td><td>France</td><td>4</td><td>12087</td><td>3.3</td><td>0.9 - 8.5</td></tr><tr><td></td><td>Greece</td><td>3</td><td>10310</td><td>2.9</td><td>0.6 - 8.5</td></tr><tr><td></td><td>Italy... |
c6946c058d82faef0ccba22ee20a94092653f736a11b4c531634167327341a2e.png | simple | <table><tr><td></td><td>Attended predictable</td><td>Attended unpredictable</td><td>Unattended predictable</td><td>Unattended unpredictable</td></tr><tr><td>Mean</td><td>175.38</td><td>171.38</td><td>171.81</td><td>173.50</td></tr><tr><td>Range</td><td>165–182</td><td>141–187</td><td>142–188</td><td>1... | <table><tr><td></td><td>Attended predictable</td><td>Attended unpredictable</td><td>Unattended predictable</td><td>Unattended unpredictable</td></tr><tr><td>Mean</td><td>175.38</td><td>171.38</td><td>171.81</td><td>173.50</td></tr></table> | <table><tr><td>Range</td><td>165–182</td><td>141–187</td><td>142–188</td><td>161–181</td></tr></table> |
114466071cf1f9c3f745b066d1392cad072fa87e408a48941173cc1476ed8bbf.png | complex | <table><tr><td rowspan="2">Texture analysis parameter</td><td colspan="3">Main effects (<i>P</i> value)</td><td colspan="4">Effect interactions (<i>P</i> value)</td></tr><tr><td>(1) Exp. day</td><td>(2) Potency</td><td>(3) Replicate</td><td>1-2</td><td>1-3</td><td>2-3</td><td>1-2-3</td></tr><tr><td>Cluster_prominence</... | <table><tr><td rowspan="2">Texture analysis parameter</td><td colspan="3">Main effects (P value)</td><td colspan="4">Effect interactions (P value)</td></tr><tr><td>(1) Exp. day</td><td>(2) Potency</td><td>(3) Replicate</td><td>1-2</td><td>1-3</td><td>2-3</td><td>1-2-3</td></tr><tr><td>Cluster_prominence</td><td><0.0001... | <table><tr><td rowspan="2">Texture analysis parameter</td><td colspan="3">Main effects (P value)</td><td colspan="4">Effect interactions (P value)</td></tr><tr><td>(1) Exp. day</td><td>(2) Potency</td><td>(3) Replicate</td><td>1-2</td><td>1-3</td><td>2-3</td><td>1-2-3</td></tr><tr><td>Correlation</td><td><0.0001*</td><... |
a14609c69827aa930bdd8521baf8c89348db858831563650967054b3d0816516.png | simple | <table><tr><td>nr</td><td>Item description</td><td>loading</td><td>α1</td><td>α2</td><td>ITC</td></tr><tr><td></td><td><i>Factor 1: Communication with ophthalmologist</i></td><td></td><td>0.89</td><td></td><td></td></tr><tr><td>Q7</td><td>Ophthalmologist treated me with respect</td><td>0.88</td><td></td><td>0... | <table><tr><td>nr</td><td>Item description</td><td>loading</td><td>α1</td><td>α2</td><td>ITC</td></tr><tr><td></td><td>Factor 1: Communication with ophthalmologist</td><td></td><td>0.89</td><td></td><td></td></tr><tr><td>Q7</td><td>Ophthalmologist treated me with respect</td><td>0.88</td><td></td><td>0.88</td><td>0.66<... | <table><tr><td>nr</td><td>Item description</td><td>loading</td><td>α1</td><td>α2</td><td>ITC</td></tr><tr><td>Q30</td><td>Nurses treat me with respect</td><td>0.84</td><td></td><td>0.66</td><td>0.56</td></tr><tr><td>Q31</td><td>Nurses listened carefully</td><td>0.84</td><td></td><td>0.59</td><td>0.63</td></tr><tr><td>Q... |
b020e2937fe5aef7458a83fc2c0ca8ad7f10c1439d2ba61c3f3e1dca27849a25.png | simple | <table><tr><td></td><td></td><td></td><td>GRADING</td><td>ADC</td><td>fp</td><td>Dp</td><td>Dt</td></tr><tr><td><i>Spearman Correlation Coefficient</i></td><td>GRADING</td><td>Correlation Coefficient</td><td>1,000</td><td>,687*</td><td>,737*</td><td>−,326</td><td>,674*</td></tr><tr><td></td><td></td><td>P value</... | <table><tr><td></td><td></td><td></td><td>GRADING</td><td>ADC</td></tr><tr><td>Spearman Correlation Coefficient</td><td>GRADING</td><td>Correlation Coefficient</td><td>1,000</td><td>,687*</td></tr><tr><td></td><td></td><td>P value</td><td></td><td>,000</td></tr><tr><td></td><td>ADC</td><td>Correlation Coefficient</td><... | <table><tr><td>fp</td><td>Dp</td><td>Dt</td></tr><tr><td>,737*</td><td>−,326</td><td>,674*</td></tr><tr><td>,000</td><td>,090</td><td>,000</td></tr><tr><td>,483*</td><td>−,128</td><td>,835*</td></tr><tr><td>,006</td><td>,518</td><td>,000</td></tr><tr><td>1,000</td><td>−,615*</td><td>,245</td></tr><tr><td></td><td>,001<... |
99bf1ec416bbbc302adf0caf2787279c052039b99917802152efe4b4881ee1f6.png | simple | <table><tr><td></td><td>n</td><td>Gender female</td><td>Age (years)*</td><td>Height (cm)*</td><td>Weight (kg)*</td><td>BMI (kg/m<sup>2</sup>)*</td></tr><tr><td>Residents</td><td>64</td><td>n = 53 (82.8%)</td><td>83.2 ± 8.1</td><td>161.9 ± 9.3</td><td>72.1 ± 16.1</td><td>27.4 ± 5.4</td></tr><tr><td>C... | <table><tr><td></td><td>n</td><td>Gender female</td><td>Age (years)*</td><td>Height (cm)*</td><td>Weight (kg)*</td><td>BMI (kg/m2)*</td></tr><tr><td>Residents</td><td>64</td><td>n = 53 (82.8%)</td><td>83.2 ± 8.1</td><td>161.9 ± 9.3</td><td>72.1 ± 16.1</td><td>27.4 ± 5.4</td></tr></table> | <table><tr><td></td><td>n</td><td>Gender female</td><td>Age (years)*</td><td>Height (cm)*</td><td>Weight (kg)*</td><td>BMI (kg/m2)*</td></tr><tr><td>Caregivers</td><td>29</td><td>n = 29 (100%)</td><td>42.0 ± 11.7</td><td>166.7 ± 6.2</td><td>76.3 ± 16.6</td><td>27.3 ± 5.9</td></tr></table> |
768cabfa072b136999e316e7303d6048955f29ef59e7c6f3e4456a1e070f66f6.png | simple | <table><tr><td>Material</td><td>Q<sup>4</sup> (%Area)</td><td>Q<sup>3</sup> (%Area)</td><td>Q<sup>2</sup> (%Area)</td></tr><tr><td>FDU-12-H100</td><td>61.75</td><td>30.82</td><td>7.43</td></tr><tr><td>FDU-12-H130</td><td>67.1</td><td>29.46</td><td>3.44</td></tr><tr><td>FDU-12-H150</td><td>70.86</td><td>26.50</td><td>2.... | <table><tr><td>Material</td><td>Q4 (%Area)</td><td>Q3 (%Area)</td><td>Q2 (%Area)</td></tr><tr><td>FDU-12-H100</td><td>61.75</td><td>30.82</td><td>7.43</td></tr><tr><td>FDU-12-H130</td><td>67.1</td><td>29.46</td><td>3.44</td></tr><tr><td>FDU-12-H150</td><td>70.86</td><td>26.50</td><td>2.64</td></tr></table> | <table><tr><td>Material</td><td>Q4 (%Area)</td><td>Q3 (%Area)</td><td>Q2 (%Area)</td></tr><tr><td>FDU-12-H180</td><td>73.86</td><td>23.91</td><td>2.23</td></tr><tr><td>FDU-12-H200</td><td>75.42</td><td>22.94</td><td>1.64</td></tr></table> |
e60d111ed137edc8654b675ac5974de40925dbdd9214917fb12154e960e63642.png | simple | <table><tr><td>CT(A, B)</td><td>McTwo</td><td>CFS</td><td>PAM</td><td>RRF</td></tr><tr><td>McTwo</td><td>0/17/0</td><td>1/2/14</td><td>12/1/4</td><td>15/0/2</td></tr><tr><td>CFS</td><td>14/2/1</td><td>0/17/0</td><td>16/1/0</td><td>17/0/0</td></tr><tr><td>PAM</td><td>4/1/12</td><td>0/1/16</td><td>0/17/0</td><td>13/0/4</... | <table><tr><td>CT(A, B)</td><td>McTwo</td><td>CFS</td><td>PAM</td><td>RRF</td></tr><tr><td>McTwo</td><td>0/17/0</td><td>1/2/14</td><td>12/1/4</td><td>15/0/2</td></tr></table> | <table><tr><td>CT(A, B)</td><td>McTwo</td><td>CFS</td><td>PAM</td><td>RRF</td></tr><tr><td>CFS</td><td>14/2/1</td><td>0/17/0</td><td>16/1/0</td><td>17/0/0</td></tr><tr><td>PAM</td><td>4/1/12</td><td>0/1/16</td><td>0/17/0</td><td>13/0/4</td></tr><tr><td>RRF</td><td>2/0/15</td><td>0/0/17</td><td>4/0/13</td><td>0/17/0</td... |
97c9542e8256d5cb075db8e1f9acd32d884b9519de031da9701ae6824c6e64c6.png | complex | <table><tr><td rowspan="2">Factors analyzed</td><td colspan="2">RAI (−) patients</td></tr><tr><td>Risk ratio (CI)</td><td><i>p</i> value</td></tr><tr><td>Age (years)</td><td>0.034 (0.000–48.227)</td><td>0.362</td></tr><tr><td>Male gender</td><td>1.170 (0.279–4.911)</td><td>0.830</td></tr><tr><td>Micro... | <table><tr><td rowspan="2">Factors analyzed</td><td colspan="2">RAI (−) patients</td></tr><tr><td>Risk ratio (CI)</td><td>p value</td></tr><tr><td>Age (years)</td><td>0.034 (0.000–48.227)</td><td>0.362</td></tr><tr><td>Male gender</td><td>1.170 (0.279–4.911)</td><td>0.830</td></tr><tr><td>Microscopic ETE</td><td>0.794 ... | <table><tr><td rowspan="2">Factors analyzed</td><td colspan="2">RAI (−) patients</td></tr><tr><td>Risk ratio (CI)</td><td>p value</td></tr><tr><td>LLND bilaterality</td><td>2.070 (0.254–16.892)</td><td>0.497</td></tr><tr><td>Multifocality</td><td>1.051 (0.211–5.239)</td><td>0.952</td></tr><tr><td>Bilaterality</td><td>0... |
419cad103c697e112363aea31d687184f5be4d3f5bac610594ec261dd2851313.png | simple | <table><tr><td>Measure</td><td>Inclusion (<i>n </i>= 165)</td><td>18 months (<i>n </i>= 156)</td><td>30 months (<i>n </i>= 149)</td></tr><tr><td>Mean M-HAQ score (median)</td><td>0.93 ± 0.64 (0.875)</td><td>0.42 ± 0.50 (0.25)</td><td>0.35 ± 0.41 (0.25)</td></tr><tr><td>No. with M-HAQ ≥ 1.0 (%)</td>... | <table><tr><td>Measure</td><td>Inclusion (n = 165)</td><td>18 months (n = 156)</td><td>30 months (n = 149)</td></tr><tr><td>Mean M-HAQ score (median)</td><td>0.93 ± 0.64 (0.875)</td><td>0.42 ± 0.50 (0.25)</td><td>0.35 ± 0.41 (0.25)</td></tr><tr><td>No. with M-HAQ ≥ 1.0 (%)</td><td>76 (46.1)</td><td>18 (11.6%)</td><td>1... | <table><tr><td>No. fulfilling criteria for RA (%)</td><td>133 (80.6)</td><td>36 (23.1)</td><td>28 (18.8)</td></tr><tr><td>No. with severe arthritis (%)</td><td>106 (64.2)</td><td>65 (41.7)</td><td>56 (37.8)</td></tr><tr><td>Mean total SvH score (median)</td><td>6.05 ± 8.38 (4)</td><td>11.34 ± 13.82 (7)</td><td>15.76 ± ... |
7620cb01f76f8b391cede1f7942eb96dc4942ed180c31ae1dfc4acd1da024c2d.png | simple | <table><tr><td>Groups</td><td>I</td><td>N</td><td>Total</td></tr><tr><td>H</td><td>5</td><td>7</td><td>12</td></tr><tr><td>L</td><td>7</td><td>4</td><td>11</td></tr><tr><td>Total</td><td>12</td><td>11</td><td>23</td></tr></table> | <table><tr><td>Groups</td><td>I</td></tr><tr><td>H</td><td>5</td></tr><tr><td>L</td><td>7</td></tr><tr><td>Total</td><td>12</td></tr></table> | <table><tr><td>N</td><td>Total</td></tr><tr><td>7</td><td>12</td></tr><tr><td>4</td><td>11</td></tr><tr><td>11</td><td>23</td></tr></table> |
d6a39cae3ff7f2c998270ddec03c21c2fd95294453d735f0ff46adb55dfd49bc.png | complex | <table><tr><td>Effect Type</td><td colspan="4">City</td></tr><tr><td></td><td>Washington</td><td>New York</td><td>Chicago</td><td>Atlanta</td></tr><tr><td>Combined Fallout and Thermal</td><td>188,430</td><td>1,649,587</td><td>614,535</td><td>182,717</td></tr><tr><td>Combined Fallout and Blast</td><td>223,570</td><td>1,... | <table><tr><td>Effect Type</td><td colspan="4">City</td></tr><tr><td></td><td>Washington</td><td>New York</td><td>Chicago</td><td>Atlanta</td></tr><tr><td>Combined Fallout and Thermal</td><td>188,430</td><td>1,649,587</td><td>614,535</td><td>182,717</td></tr><tr><td>Combined Fallout and Blast</td><td>223,570</td><td>1,... | <table><tr><td>Effect Type</td><td colspan="4">City</td></tr><tr><td></td><td>Washington</td><td>New York</td><td>Chicago</td><td>Atlanta</td></tr><tr><td>3–10psi</td><td>9,194</td><td>46,515</td><td>33,410</td><td>12,949</td></tr><tr><td>2–3psi ***</td><td>22,532</td><td>55,126</td><td>23,360</td><td>15,278</td></tr><... |
6a9d8094171d1c24043f9ae56be890f4de05d8239889431e3aabf6956b7ce204.png | simple | <table><tr><td>Cluster</td><td>Observed cases</td><td>Expected Cases</td><td>RR</td><td>LLR</td><td><i>P </i>value</td></tr><tr><td>(a) Without covariate adjustment</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Most likely cluster</td><td>3388</td><td>2754.18</td><td>1.27</td><td>78.04</td><td><0.001... | <table><tr><td>Cluster</td><td>Observed cases</td><td>Expected Cases</td><td>RR</td><td>LLR</td><td>P value</td></tr><tr><td>(a) Without covariate adjustment</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Most likely cluster</td><td>3388</td><td>2754.18</td><td>1.27</td><td>78.04</td><td><0.001</td></tr>... | <table><tr><td>Secondary cluster 1</td><td>476</td><td>363.25</td><td>1.32</td><td>16.21</td><td><0.001</td></tr><tr><td>Not significant cluster</td><td>119</td><td>85.39</td><td>1.40</td><td>5.91</td><td>0.26</td></tr><tr><td>Not significant cluster</td><td>1209</td><td>1111.12</td><td>1.09</td><td>4.41</td><td>0.68</... |
eb84e2167bd5ab3791997c853a9348bb6a312271a9e27d3abdf16d403b2edc60.png | simple | <table><tr><td> </td><td> </td><td>NIHSS</td><td>MMSE</td></tr><tr><td>Man, 84 years</td><td>He fell when he put his glasses on the small table beside his bed</td><td>5</td><td>27</td></tr><tr><td>Man, 86 years</td><td>He fell on his way from the bedroom to the kitchen</td><td>2</td><td>23</td></tr><tr><td>Woman, 73 ye... | <table><tr><td></td><td></td><td>NIHSS</td><td>MMSE</td></tr><tr><td>Man, 84 years</td><td>He fell when he put his glasses on the small table beside his bed</td><td>5</td><td>27</td></tr></table> | <table><tr><td>Man, 86 years</td><td>He fell on his way from the bedroom to the kitchen</td><td>2</td><td>23</td></tr><tr><td>Woman, 73 years</td><td>She fell when the door of the elevator hit her</td><td>6</td><td>29</td></tr><tr><td>Man, 77 years</td><td>The staff at his nursing home found him on the floor in the bat... |
6191bdbeb3c7891a9c95d16ae309d183b091e9f4726b04e5063fbb741a0b5921.png | simple | <table><tr><td>Class</td><td>Subclass</td><td>Pathway</td></tr><tr><td>Biosynthesis</td><td>Polyamines</td><td>Betaine biosynthesis</td></tr><tr><td></td><td></td><td>Polyamine biosynthesis</td></tr><tr><td></td><td>Fatty acids and lipids</td><td>Phospholipid biosynthesis</td></tr><tr><td></td><td></td><td>Fatty acid b... | <table><tr><td>Class</td><td>Subclass</td><td>Pathway</td></tr><tr><td>Biosynthesis</td><td>Polyamines</td><td>Betaine biosynthesis</td></tr><tr><td></td><td></td><td>Polyamine biosynthesis</td></tr><tr><td></td><td>Fatty acids and lipids</td><td>Phospholipid biosynthesis</td></tr><tr><td></td><td></td><td>Fatty acid b... | <table><tr><td></td><td></td><td>Polyisoprenoid biosynthesis</td></tr><tr><td></td><td></td><td>FormylTHF biosynthesis</td></tr><tr><td></td><td>Cell structures</td><td>Colanic acid building blocks biosynthesis</td></tr><tr><td></td><td></td><td>GDP-mannose metabolism</td></tr><tr><td></td><td>Carbohydrates</td><td>Glu... |
183e5bdec20b755244ce81fa7c82dd763316b8e4aa5fe3cc7385ea21eda2a172.png | simple | <table><tr><td></td><td>Multiple sclerosis</td><td>Normal controls</td></tr><tr><td>Number</td><td><i>N</i> = 31</td><td><i>N</i> = 18</td></tr><tr><td>Age (years) (mean ± SD)</td><td>43.3 ± 8.7</td><td>43.6 ± 8.1</td></tr><tr><td>Women, number (%)</td><td>21 (68 %)</td><td>14 (78 %)</td></tr><tr><td>Dis... | <table><tr><td></td><td>Multiple sclerosis</td><td>Normal controls</td></tr><tr><td>Number</td><td>N = 31</td><td>N = 18</td></tr><tr><td>Age (years) (mean ± SD)</td><td>43.3 ± 8.7</td><td>43.6 ± 8.1</td></tr></table> | <table><tr><td></td><td>Multiple sclerosis</td><td>Normal controls</td></tr><tr><td>Women, number (%)</td><td>21 (68 %)</td><td>14 (78 %)</td></tr><tr><td>Disease category, number (%)</td><td></td><td></td></tr><tr><td>Relapsing-remitting</td><td>26 (84 %)</td><td>-</td></tr><tr><td>Secondary progressive</td><td>4 (13 ... |
74de41c6871aade83706cdf17687df34cc88545064827358918a367d8530d919.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">All</td><td colspan="2">Non-C9/GRN</td><td colspan="2"><i>C9orf72</i></td><td colspan="2"><i>GRN</i></td></tr><tr><td>pTDP-43</td><td>NeuN</td><td>pTDP-43</td><td>NeuN</td><td>pTDP-43</td><td>NeuN</td><td>pTDP-43</td><td>NeuN</td></tr><tr><td>Range</td><td>0-308.8</td><td... | <table><tr><td rowspan="2"></td><td colspan="2">All</td><td colspan="2">Non-C9/GRN</td><td colspan="2">C9orf72</td><td colspan="2">GRN</td></tr><tr><td>pTDP</td><td>NeuN</td><td>pTDP-4</td><td>N</td><td></td><td>Ne</td><td>p</td><td>Ne</td></tr></table> | <table><tr><td></td><td>-43</td><td></td><td>3</td><td>euN</td><td>pTDP-43</td><td>uN</td><td>TDP-43</td><td>uN</td></tr><tr><td>Range</td><td>0-308.8</td><td>0-777.9</td><td>0.3-195.1</td><td>0-777.9</td><td>0-194.2</td><td>0.1-740.2</td><td>0.3-308.8</td><td>0.6-640.7</td></tr><tr><td>Median</td><td>14.0</td><td>118.... |
8eb82f4cff66f2cb27ff87bc8c4cc9198d53c465c59c49c7694c2bd9b6b4732a.png | complex | <table><tr><td rowspan="2">PWM</td><td colspan="4">GATA-3 bound sequences</td><td colspan="3">GATA-3 not bound sequences</td></tr><tr><td>Total hits</td><td>TP sequences</td><td>FN</td><td>Sensitivity</td><td>Total hits</td><td>Total sequences with hits</td><td>TN</td></tr><tr><td>New-mono</td><td>45095</td><td>21289</... | <table><tr><td rowspan="2">PWM</td><td colspan="4">GATA-3 bound sequences</td><td colspan="3">GATA-3 not bound sequences</td></tr><tr><td>Total hits</td><td>TP sequences</td><td>FN</td><td>Sensitivity</td><td>Total hits</td><td>Total sequences with hits</td><td>TN</td></tr><tr><td>New-mono</td><td>45095</td><td>21289</... | <table><tr><td>Match_minFN</td><td>102257</td><td>27158</td><td>1171</td><td>96%</td><td>97461</td><td>27071</td><td>1258</td></tr><tr><td>Match_minFP</td><td>673</td><td>663</td><td>27666</td><td>2.38%</td><td>639</td><td>630</td><td>27699</td></tr><tr><td>Match_minSUM</td><td>14988</td><td>11436</td><td>16893</td><td... |
a1d6ccec1652c4cbc56ca4dba230974b338a529ecbfacba9a5c81ba5c6433971.png | complex | <table><tr><td colspan="2">Study</td><td>Conduit</td><td colspan="2">Number of patients</td><td colspan="2">Skeletonized Group</td><td>Key Findings</td><td>Adverse Events</td></tr><tr><td>Ref</td><td>Type</td><td>RA/GEA</td><td>Skel</td><td>Control</td><td>Age (Yrs ± S.D.)</td><td>Gender M/F</td><td></td><td></td>... | <table><tr><td colspan="2">Study</td><td>Conduit</td><td colspan="2">Number of patients</td><td colspan="2">Skeletonized Group</td><td>Key Findings</td><td>Adverse Events</td></tr><tr><td>Re</td><td></td><td>RA</td><td>Skel</td><td>Contro</td><td>Age (Yrs ±</td><td>Gender</td><td></td><td></td></tr></table> | <table><tr><td>f</td><td>Type</td><td>/GEA</td><td></td><td>l</td><td> S.D.)</td><td> M/F</td><td></td><td></td></tr><tr><td>Kamiya et al [13]</td><td>A</td><td>GEA</td><td>70</td><td>98</td><td>60 ± 9.2</td><td>51/80</td><td>Significantly increases luminal diameter Composite grafts effective for multiple grafting</td>... |
607d28f999cfd0da8bd4c417733e0287557e380eaa3a3e5623e29f2994f7ec92.png | simple | <table><tr><td>Trial Characteristics</td><td>Percent (number) of Trials</td></tr><tr><td>Study Type</td><td></td></tr><tr><td> Individual patient RCT</td><td>76.25% (61/80)</td></tr><tr><td> Factorial RCT</td><td>6.25% (5/80)</td></tr><tr><td> Cluster RCT</td><td>17.5% (14/80)</td></tr><tr><td>Number of study arms</td>... | <table><tr><td>Trial Characteristics</td><td>Percent (number) of Trials</td></tr><tr><td>Study Type</td><td></td></tr><tr><td>Individual patient RCT</td><td>76.25% (61/80)</td></tr><tr><td>Factorial RCT</td><td>6.25% (5/80)</td></tr><tr><td>Cluster RCT</td><td>17.5% (14/80)</td></tr><tr><td>Number of study arms</td><td... | <table><tr><td>GCP adherence reported</td><td>6.25% YES (5/80)</td></tr><tr><td>Lead Investigator reports previous research experience</td><td>62.5% YES (50/80)</td></tr><tr><td>Trial results</td><td></td></tr><tr><td>Harm</td><td>2.5% (2/80)</td></tr><tr><td>Neutral</td><td>32.5% (26/80)</td></tr><tr><td>Positive</td>... |
18d29053d86beac4a77c7bbb006b4c60fc6c7d4583fb4a295f57952607815b12.png | complex | <table><tr><td></td><td colspan="4">Primary cultures</td></tr><tr><td>Gene</td><td colspan="2">oJIA (n = 12)</td><td colspan="2">pJIA (n = 4)</td></tr><tr><td></td><td>Day 14</td><td>Day 21</td><td>Day 14</td><td>Day 21</td></tr><tr><td><i>Runx2</i></td><td>0.02 (0.01-0.07)</td><td>0.05 (0.02-0.11)</td><td>0.00 (0.00-0... | <table><tr><td></td><td colspan="4">Primary cultures</td></tr><tr><td>Gene</td><td colspan="2">oJIA (n = 12)</td><td colspan="2">pJIA (n = 4)</td></tr><tr><td></td><td>Day 14</td><td>Day 21</td><td>Day 14</td><td>Day 21</td></tr><tr><td>Runx2</td><td>0.02 (0.01-0.07)</td><td>0.05 (0.02-0.11)</td><td>0.00 (0.00-0.01)</t... | <table><tr><td></td><td colspan="4">Primary cultures</td></tr><tr><td>Gene</td><td colspan="2">oJIA (n = 12)</td><td colspan="2">pJIA (n = 4)</td></tr><tr><td></td><td>Day 14</td><td>Day 21</td><td>Day 14</td><td>Day 21</td></tr><tr><td></td><td colspan="4"> cultures</td></tr><tr><td></td><td colspan="2">oJIA (n = 7)</... |
0c6dfc850c825e5b3c181348c78e98bd510608b9a7e76a78647f949003762996.png | simple | <table><tr><td>Transmission route</td><td>Cases (n = 30)</td><td>Controls(n = 50)</td><td>Odds ratio</td><td>95% Confidence intervals</td><td><i>P</i> value</td></tr><tr><td>Blood transfusion (without proper screening)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> • Yes</td><td>11</td><td>7</td><... | <table><tr><td>Transmission route</td><td>Cases (n = 30)</td><td>Controls(n = 50)</td><td>Odds ratio</td><td>95% Confidence intervals</td><td>P value</td></tr><tr><td>Blood transfusion (without proper screening)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>• Yes</td><td>11</td><td>7</td><td>3.56</td><t... | <table><tr><td>• Yes</td><td>12</td><td>11</td><td>3.87</td><td>1.192–12.827</td><td>0.021</td></tr><tr><td>• No</td><td>18</td><td>39</td><td>1.00</td><td>(Reference)</td><td></td></tr></table> |
b73c4930b564bcfdee295ca6ef67a38cb584d372080d92135813d1a22ba5d04e.png | simple | <table><tr><td>Targeted protein</td><td>Peptide number</td><td>Sequence</td><td>Specificity Tm.I/Tm.II<sup>#</sup></td><td>Global proteomics 2007 study (Bertin et al., 2011)</td><td>Cell cultures</td><td>2007 COWG</td><td>2009 COWG</td><td>2009 COWG</td><td>2011 COWG</td><td>2012 COWG</td></tr><tr><td>AioA</td><td>1</t... | <table><tr><td>Targeted protein</td><td>Peptide number</td><td>Sequence</td><td>Specificity Tm.I/Tm.II#</td><td>Global proteomics 2007 study (Bertin et al., 2011)</td><td>Cell cultures</td><td>2007 COWG</td><td>2009 COWG</td><td>2009 COWG</td><td>2011 COWG</td><td>2012 COWG</td></tr><tr><td>AioA</td><td>1</td><td>ACVVN... | <table><tr><td></td><td>9</td><td>IQVFPAK</td><td>Tm.I/Tm.II</td><td>–</td><td>CB1, CB2, CB3, CB6</td><td>X</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td></td><td>10</td><td>ITGVPVAQIK</td><td>Tm.I/Tm.II</td><td>X</td><td>CB1, CB2, CB3, CB6</td><td>X</td><td>X</td><td>X</td><td>X</td><td>X</td></tr><tr><td><... |
59bd3bb6c26cf372f936d6d7a85256ec398adf826e424b556e9a99a304a47d51.png | simple | <table><tr><td></td><td>No type 2 diabetes (<i>n</i> = 609)</td><td>Type 2 diabetes (<i>n</i> = 253)</td><td><i>p</i>-value</td></tr><tr><td>Age, years</td><td>58 ± 8.6</td><td>64 ± 7.0</td><td>< 0.001</td></tr><tr><td>Male sex, n (%)</td><td>296 (49 %)</td><td>176 (70 %)</td><td>< 0.001</td></tr><tr><t... | <table><tr><td></td><td>No type 2 diabetes (n = 609)</td></tr><tr><td>Age, years</td><td>58 ± 8.6</td></tr><tr><td>Male sex, n (%)</td><td>296 (49 %)</td></tr><tr><td>Partner, n (%)</td><td>515 (85 %)</td></tr><tr><td>Educational level, % low/middle/high</td><td>12/39/49</td></tr><tr><td>HbA1c, %</td><td>5.65 ± 0.37</t... | <table><tr><td>Type 2 diabetes (n = 253)</td><td>p-value</td></tr><tr><td>64 ± 7.0</td><td>< 0.001</td></tr><tr><td>176 (70 %)</td><td>< 0.001</td></tr><tr><td>208 (85 %)</td><td>0.98</td></tr><tr><td>28/47/25</td><td><0.001</td></tr><tr><td>6.91 ± 0.88</td><td>< 0.001</td></tr><tr><td>7 [3–11]</td><td></td></tr><tr><t... |
9847b4a38334ad81432b0904a509fae2f7ac25a81085c88f6e8cc5f458c04865.png | complex | <table><tr><td>Primary clinical diagnostic category</td><td>All diagnoses included in primary clinical diagnostic categories</td></tr><tr><td rowspan="2">I. Non-Proliferative*</td><td>Non-Proliferative only</td></tr><tr><td>Fibroadenoma</td></tr><tr><td rowspan="6">II. Proliferative changes without atypia</td><td>Usual... | <table><tr><td>Primary clinical diagnostic category</td></tr><tr><td rowspan="2">I. Non-Proliferative*</td></tr><tr></tr><tr><td rowspan="6">II. Proliferative changes without atypia</td></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr></tr><tr><td rowspan="2">III. Atypical ductal hyperplasia (ADH)</td></tr><tr></tr><tr><td... | <table><tr><td>All diagnoses included in primary clinical diagnostic categories</td></tr><tr><td>Non-Proliferative only</td></tr><tr><td>Fibroadenoma</td></tr><tr><td>Usual ductal hyperplasia</td></tr><tr><td>Columnar cell hyperplasia/columnar cell changes</td></tr><tr><td>Sclerosing adenosis</td></tr><tr><td>Radial Sc... |
ab6e7c5f31ef77194822946838d7cf53772eedbbdb1af4b20f115b3278c5aaeb.png | simple | <table><tr><td>Genotype</td><td>Case Number</td><td>Percentage (%)</td></tr><tr><td>CYP2D6*2</td><td>74</td><td>100</td></tr><tr><td> CC</td><td>59</td><td>79.7</td></tr><tr><td> CT</td><td>9</td><td>12.1</td></tr><tr><td> TT</td><td>6</td><td>8.1</td></tr><tr><td>CYP2D6*10</td><td>83</td><td>100</td></tr><tr><td> CC</... | <table><tr><td>Genotype</td><td>Case Number</td><td>Percentage (%)</td></tr><tr><td>CYP2D6*2</td><td>74</td><td>100</td></tr><tr><td>CC</td><td>59</td><td>79.7</td></tr><tr><td>CT</td><td>9</td><td>12.1</td></tr><tr><td>TT</td><td>6</td><td>8.1</td></tr><tr><td>CYP2D6*10</td><td>83</td><td>100</td></tr><tr><td>CC</td><... | <table><tr><td>CYP1A2*1 F</td><td>77</td><td>100</td></tr><tr><td>CC</td><td>33</td><td>42.9</td></tr><tr><td>CA</td><td>11</td><td>14.3</td></tr><tr><td>AA</td><td>33</td><td>42.9</td></tr></table> |
1a4ec138716c69fca8e1092d27cdee0adf45568d5fe2aa3fc93d57ce609a8599.png | complex | <table><tr><td></td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td></td><td>HR (95 % CI)</td><td><i>P</i>-value</td><td>HR (95 % CI)</td><td><i>P</i>-value</td></tr><tr><td>Control</td><td colspan="4">Reference</td></tr><tr><td>HBV</td><td>1.291 (0.635-2.624)</td><td>0.48... | <table><tr><td></td><td colspan="2">Univariate analysis</td><td colspan="2">Multivariate analysis</td></tr><tr><td></td><td>HR (95 % CI)</td><td>P-value</td><td>HR (95 % CI)</td><td>P-value</td></tr><tr><td>Control</td><td colspan="4">Reference</td></tr><tr><td>HBV</td><td>1.291 (0.635-2.624)</td><td>0.481</td><td>1.32... | <table><tr><td>HBV+HCV</td><td>9.273 (2.793-30.788)</td><td><0.001</td><td>9.401 (2.691-32.841)</td><td><0.001</td></tr><tr><td>Age, per year</td><td>1.025 (1.007-1.043)</td><td>0.005</td><td>1.034 (1.013-1.054)</td><td>0.001</td></tr><tr><td>HCC</td><td>3.361 (1.212-9.322)</td><td>0.020</td><td>1.790 0.598-5.356)</td>... |
f99690ec84e850d151b440e05bff54ee2254e02587fb2a41daf56abdbe140a81.png | simple | <table><tr><td>Feature</td><td><i>FluxTransgenics</i></td><td><i>Phytotracker</i></td><td><i>QTreds</i></td></tr><tr><td>Operational system</td><td>Web Application, can be accessed from any OS.</td><td>Mac OS or Microsoft Windows.</td><td>Web Application, can be accessed from any OS.</td></tr><tr><td>Data storage</td><... | <table><tr><td>Feature</td><td>FluxTransgenics</td><td>Phytotracker</td><td>QTreds</td></tr><tr><td>Operational system</td><td>Web Application, can be accessed from any OS.</td><td>Mac OS or Microsoft Windows.</td><td>Web Application, can be accessed from any OS.</td></tr></table> | <table><tr><td>Feature</td><td>FluxTransgenics</td><td>Phytotracker</td><td>QTreds</td></tr><tr><td>Data storage</td><td>MySQL Relational Database.</td><td>FileMaker Pro.</td><td>MySQL Relational Database.</td></tr><tr><td>Process support</td><td>Most laboratory processes. Adaptable to any workflow.</td><td>Pre-defined... |
1f4ec984d1ce2132349d6f69acee5a9919b1356f48bb743628c800f4c78cf08f.png | complex | <table><tr><td>Genetic characteristic</td><td>Frequency,%</td></tr><tr><td colspan="2"><i>VKORC1</i> (N = 96)</td></tr><tr><td colspan="2"> Gene</td></tr><tr><td>GG (wild type)</td><td>84 (87.5)</td></tr><tr><td>GA</td><td>12 (12.5)</td></tr><tr><td>AA</td><td>–</td></tr><tr><td colspan="2"> Allele</td></tr><tr><... | <table><tr><td>Genetic characteristic</td><td>Frequency,%</td></tr><tr><td colspan="2">VKORC1 (N = 96)</td></tr><tr><td colspan="2">Gene</td></tr><tr><td>GG (wild type)</td><td>84 (87.5)</td></tr><tr><td>GA</td><td>12 (12.5)</td></tr><tr><td>AA</td><td>–</td></tr><tr><td colspan="2">Allele</td></tr><tr><td>G</td><td>18... | <table><tr><td>T</td><td>96 (41.4)</td></tr><tr><td colspan="2">CYP2C9*2 (N = 86)</td></tr><tr><td colspan="2">Gene</td></tr><tr><td>CC (wild type)</td><td>86 (100)</td></tr><tr><td>CT</td><td>–</td></tr><tr><td>TT</td><td>–</td></tr><tr><td colspan="2">Allele</td></tr><tr><td>C</td><td>172 (100)</td></tr><tr><td>T</td... |
01d33ba53168ecf20108cc7ea7ee5ab120eeb2a5d970427bf2d6e45dd536bc65.png | complex | <table><tr><td>Variable</td><td>PC1</td><td>PC2</td><td>PC3</td></tr><tr><td>Feeding score in glass-house (Day 7)</td><td>0.278</td><td>–0.245</td><td>0.065</td></tr><tr><td>Feeding score in glass-house (Day 13)</td><td>0.239</td><td>–0.305</td><td>0.014</td></tr><tr><td><i>In vitro</i> M-C feeding damage (... | <table><tr><td>Variable</td><td>PC1</td><td>PC2</td><td>PC3</td></tr></table> | <table><tr><td>Feeding score in glass-house (Day 7)</td><td>0.278</td><td>–0.245</td><td>0.065</td></tr><tr><td>Feeding score in glass-house (Day 13)</td><td>0.239</td><td>–0.305</td><td>0.014</td></tr><tr><td>In vitro M-C feeding damage (12 h)</td><td>0.175</td><td>0.003</td><td>–0.304</td></tr><tr><td>In vitro T-C fe... |
1fee6d6f2421fd84c7c3978f682eb696fc8da934739a91a136ca1d224bbf59cd.png | complex | <table><tr><td></td><td>ASAQ</td><td>AL</td></tr><tr><td>No. of included patients (intention-to-treat)</td><td>62</td><td>61</td></tr><tr><td colspan="3">PCR-uncorrected responses on day 28</td></tr><tr><td> Withdrawn or lost to follow up: N; % (95 % CI)</td><td>7; 11.3 (4.7–21.9)</td><td>9; 14.8 (7.0–26.2)... | <table><tr><td></td><td>ASAQ</td><td>AL</td></tr><tr><td>No. of included patients (intention-to-treat)</td><td>62</td><td>61</td></tr><tr><td colspan="3">PCR-uncorrected responses on day 28</td></tr><tr><td>Wit</td><td>7; </td><td>9; 1</td></tr></table> | <table><tr><td>hdrawn or lost to follow up: N; % (95 % CI)</td><td>11.3 (4.7–21.9)</td><td>4.8 (7.0–26.2)</td></tr><tr><td>Per protocol population: N; % (95 % CI)</td><td>55; 88.7 (78.1–95.3)</td><td>52; 85.2 (73.8–93.0)</td></tr><tr><td>Failures: N; % (95 % CI)</td><td>4; 7.3 (2.0–17.6)</td><td>4; 7.7 (2.1–18.5)</td><... |
3462aef9a8f46995606d533d610414563f161f6489d35a6084e9d67aa98b25bc.png | simple | <table><tr><td></td><td><1 y</td><td>1-4 y</td><td>5-9 y</td><td>10-14 y</td><td>15-19 y</td><td>20-29 y</td><td><underline>></underline>30 y</td></tr><tr><td></td><td>n=62 (%)</td><td>n=75 (%)</td><td>n=10 (%)</td><td>n=9 (%)</td><td>n=35</td><td>n=41</td><td>n=52</td></tr><tr><td>Bronchopneumonia (n=227)</td><t... | <table><tr><td></td><td><1 y</td><td>1-4 y</td><td>5-9 y</td><td>10-14 y</td><td>15-19 y</td><td>20-29 y</td><td>>30 y</td></tr><tr><td></td><td>n=62 (%)</td><td>n=75 (%)</td><td>n=10 (%)</td><td>n=9 (%)</td><td>n=35</td><td>n=41</td><td>n=52</td></tr><tr><td>Bronchopneumonia (n=227)</td><td>46 (74.2%)</td><td>61 (81.3... | <table><tr><td></td><td><1 y</td><td>1-4 y</td><td>5-9 y</td><td>10-14 y</td><td>15-19 y</td><td>20-29 y</td><td>>30 y</td></tr><tr><td>Epistaxis (n=2)</td><td></td><td></td><td></td><td></td><td></td><td>2 (4.9%)</td><td></td></tr><tr><td>Chronic bronchitis (n=5)</td><td>3 (4.8%)</td><td>2 (2.7%)</td><td></td><td></td... |
2e7ff15644a74cef39d85b051f5823973fe5f35d5cad506a63bdc036c59ae6de.png | complex | <table><tr><td></td><td></td><td>SKO</td></tr><tr><td colspan="2">WASI matrix reasoning</td><td>18/32 (<i>T</i> = 49)</td></tr><tr><td colspan="2">Digit span forwards</td><td>3 digits</td></tr><tr><td colspan="2">Repetition</td><td>63/90</td></tr><tr><td colspan="2">Reading [from Brown and Ure (1969)]</td><td>11/72</td... | <table><tr><td></td><td></td><td>SKO</td></tr><tr><td colspan="2">WASI matrix reasoning</td><td>18/32 (T = 49)</td></tr><tr><td colspan="2">Digit span forwards</td><td>3 digits</td></tr><tr><td colspan="2">Repetition</td><td>63/90</td></tr><tr><td colspan="2">Reading [from Brown and Ure (1969)]</td><td>11/72</td></tr><... | <table><tr><td></td><td>dy part</td><td>(30%)</td></tr><tr><td></td><td>Countries</td><td>9/10 (90%)</td></tr><tr><td></td><td>TOTAL</td><td>20/50 (40%)</td></tr><tr><td>Comprehension</td><td>Animals</td><td>10/10 (100%)</td></tr><tr><td></td><td>Man-made artifacts</td><td>10/10 (100%)</td></tr><tr><td></td><td>Colors<... |
d07bcbebdd8e571392f03ab36bca8eee19f386433aca270ae47be86af062cb6c.png | complex | <table><tr><td>Flow type</td><td>The flow is fast and in vasculitis direction and velocity are important for diagnosis</td></tr><tr><td rowspan="6">PRF and wall filters</td><td>Different PRF for different vessels:</td></tr><tr><td> Temporal and facial arteries, PRF range = 2–3.5 kHz</td></tr><tr><td> Carotis, sub... | <table><tr><td>Flow type</td><td>The flow is fast and in vasculitis direction and velocity are important for diagnosis</td></tr><tr><td rowspan="6">PRF and wall filters</td><td>Different PRF for different vessels:</td></tr><tr><td>Temporal and facial arteries, PRF range = 2–3.5 kHz</td></tr><tr><td>Carotis, subclavian ... | <table><tr><td>Flow type</td><td>The flow is fast and in vasculitis direction and velocity are important for diagnosis</td></tr><tr><td rowspan="2">Choice of Doppler</td><td>CD as it displays the mean blood velocity</td></tr><tr><td>Spectral Doppler for indicating correct insonation angle and for calculating the correc... |
31067e64d14ff2d446f556899fea913262bf5f2be2f98c40ea208bfc53a5aed6.png | complex | <table><tr><td>Parameter</td><td colspan="3">Logistic Regression</td></tr><tr><td></td><td>Odds Ratio</td><td>95% CI</td><td><i>P</i>-value</td></tr><tr><td>Women's age (years)</td><td>0.96</td><td>0.87 to 1.06</td><td>0.44</td></tr><tr><td>Men's age (years)</td><td>0.98</td><td>0.91 to 1.05</td><td>0.61</td></tr><tr><... | <table><tr><td>Parameter</td></tr><tr><td></td></tr><tr><td>Women's age (years)</td></tr><tr><td>Men's age (years)</td></tr><tr><td>Duration of infertility (years)</td></tr><tr><td>MSOME (%)-Normal spermatozoa</td></tr><tr><td>Follicles ≥17 mm (n)</td></tr><tr><td>DNA fragmentation (%)</td></tr><tr><td>Total sperm coun... | <table><tr><td colspan="3">Logistic Regression</td></tr><tr><td>Odds Ratio</td><td>95% CI</td><td>P-value</td></tr><tr><td>0.96</td><td>0.87 to 1.06</td><td>0.44</td></tr><tr><td>0.98</td><td>0.91 to 1.05</td><td>0.61</td></tr><tr><td>0.81</td><td>0.63 to 1.03</td><td>0.10</td></tr><tr><td>1.28</td><td>1.08 to 1.51</td... |
aa9dd60931b0a61abb2fa9785792c2c1a834330ec1e11b810471e7ad86ecacf7.png | simple | <table><tr><td>Facilitators</td><td>N</td><td>Barriers</td><td>N</td></tr><tr><td>Concern over impacts of smoking on children’s health</td><td>22</td><td>Light smoking</td><td>10</td></tr><tr><td>Economic concern</td><td>20</td><td>Refusal of use of smoking cessation aids</td><td>9</td></tr><tr><td>Different smok... | <table><tr><td>Facilitators</td><td>N</td><td>Barriers</td><td>N</td></tr><tr><td>Concern over impacts of smoking on children’s health</td><td>22</td><td>Light smoking</td><td>10</td></tr><tr><td>Economic concern</td><td>20</td><td>Refusal of use of smoking cessation aids</td><td>9</td></tr><tr><td>Different smoking en... | <table><tr><td>Smoking cessation supports from health professionals</td><td>8</td><td>The need for coping stress, and killing time</td><td>8</td></tr><tr><td>Concern over impacts of smoking on own health</td><td>11</td><td></td><td></td></tr></table> |
bd886b527a29e7039a3d37ce375faf26451bebe6e21e9577b4f60435c000eb92.png | simple | <table><tr><td>Position and academic responsibility</td><td>All (n = 993)</td><td>Community-based (n = 294)</td><td>DGH-based (n = 412)</td><td>Tertiary (n = 279)</td></tr><tr><td>Consultants</td><td>84%</td><td>60%</td><td>96%</td><td>96%</td></tr><tr><td>Non-consultant career grades</td><td>12%</td><td>34%</td><td>4%... | <table><tr><td>Position and academic responsibility</td><td>All (n = 993)</td><td>Community-based (n = 294)</td><td>DGH-based (n = 412)</td><td>Tertiary (n = 279)</td></tr><tr><td>Consultants</td><td>84%</td><td>60%</td><td>96%</td><td>96%</td></tr><tr><td>Non-consultant career grades</td><td>12%</td><td>34%</td><td>4%... | <table><tr><td>Position and academic responsibility</td><td>All (n = 993)</td><td>Community-based (n = 294)</td><td>DGH-based (n = 412)</td><td>Tertiary (n = 279)</td></tr><tr><td>ademic responsibility</td><td>18%</td><td>%</td><td>%</td><td>6%</td></tr></table> |
8cc32d3d165041fa11f24d791ea564d67d9d850bf6b9c13c542db60ff1787823.png | complex | <table><tr><td>Parameter</td><td><i>n</i> (%)</td></tr><tr><td colspan="2">Operational procedure</td></tr><tr><td> TEA</td><td>22 (40.7)</td></tr><tr><td> Thrombectomy/embolectomy</td><td>14 (25.9)</td></tr><tr><td> Bypass</td><td>13 (24.1)</td></tr><tr><td> Resection of the dissection membrane</td><td>11 (20.3)</td></... | <table><tr><td>Parameter</td></tr><tr><td>Operational procedure</td></tr><tr><td>TEA</td></tr><tr><td>Thrombectomy/embolectomy</td></tr><tr><td>Bypass</td></tr><tr><td>Resection of the dissection membrane</td></tr><tr><td>SMA-transposition</td></tr><tr><td>Visceral surgery</td></tr><tr><td>Explorative laparotomy</td></... | <table><tr><td>n (%)</td></tr><tr><td>Operational procedure</td></tr><tr><td>22 (40.7)</td></tr><tr><td>14 (25.9)</td></tr><tr><td>13 (24.1)</td></tr><tr><td>11 (20.3)</td></tr><tr><td>7 (13.0)</td></tr><tr><td>8 (14.8)</td></tr><tr><td>3 (5.6)</td></tr><tr><td>Cause of occlusion</td></tr><tr><td>16 (29.6)</td></tr><tr... |
f9e7bbf645d7597be474da3d53c79b620c7d724a765d90b5743dda526d316413.png | complex | <table><tr><td rowspan="3">DNA Source</td><td colspan="8">Position in MYD88 Exon 5 Amplicon</td></tr><tr><td colspan="2">19t</td><td colspan="2">+58g</td><td colspan="2">+1245a</td><td colspan="2">+1524t</td></tr><tr><td>SMRT</td><td>Illumina</td><td>SMRT</td><td>Illumina</td><td>SMRT</td><td>Illumina</td><td>SMRT</td>... | <table><tr><td rowspan="3">DNA Source</td><td colspan="8">Position in MYD88 Exon 5 Amplicon</td></tr><tr><td colspan="2">19t</td><td colspan="2">+58g</td><td colspan="2">+1245a</td><td colspan="2">+1524t</td></tr><tr><td>SMRT</td><td>Illumina</td><td>SMRT</td><td>Illumina</td><td>SMRT</td><td>Illumina</td><td>SMRT</td>... | <table><tr><td rowspan="3">DNA Source</td><td colspan="8">Position in MYD88 Exon 5 Amplicon</td></tr><tr><td colspan="2">19t</td><td colspan="2">+58g</td><td colspan="2">+1245a</td><td colspan="2">+1524t</td></tr><tr><td>SMRT</td><td>Illumina</td><td>SMRT</td><td>Illumina</td><td>SMRT</td><td>Illumina</td><td>SMRT</td>... |
af5aefe0ba4cfe0308cfcba9755a7ad5314fb71dd345f2d99184df5cc58738be.png | simple | <table><tr><td></td><td>Placebo</td><td>Rapid CORT</td><td>Slow CORT</td></tr><tr><td>Reaction times neutral, in ms</td><td>674(17)</td><td>702(23)</td><td>650(20)</td></tr><tr><td>Reaction times aversive, in ms</td><td>687(17)</td><td>709(23)</td><td>664(20)</td></tr><tr><td>Emotional interference on reaction times, i... | <table><tr><td></td><td>Placebo</td><td>Rapid CORT</td><td>Slow CORT</td></tr><tr><td>Reaction times neutral, in ms</td><td>674(17)</td><td>702(23)</td><td>650(20)</td></tr></table> | <table><tr><td></td><td>Placebo</td><td>Rapid CORT</td><td>Slow CORT</td></tr><tr><td>Reaction times aversive, in ms</td><td>687(17)</td><td>709(23)</td><td>664(20)</td></tr><tr><td>Emotional interference on reaction times, in Δms</td><td>12(7)</td><td>7(7)</td><td>14(6)</td></tr><tr><td>Correct responses neutral, in %... |
70110ff4552cbccb4c29a9caed6f40466ec393fcd35557e50462e420d257d3e0.png | complex | <table><tr><td></td><td></td><td colspan="3">Factor</td></tr><tr><td></td><td>Items</td><td>1</td><td>2</td><td>3</td></tr><tr><td>5.</td><td>Did you understand the method for border molding at the buccal side?</td><td>.957</td><td>.029</td><td>−.087</td></tr><tr><td>7.</td><td>Did you understand the method for b... | <table><tr><td></td><td></td><td colspan="3">Factor</td></tr><tr><td></td><td>Items</td><td>1</td><td>2</td><td>3</td></tr><tr><td>5.</td><td>Did you understand the method for border molding at the buccal side?</td><td>.957</td><td>.029</td><td>−.087</td></tr><tr><td>7.</td><td>Did you understand the method for border ... | <table><tr><td>2.</td><td>Did you understand how to use the alcohol torch?</td><td>.446</td><td>.129</td><td>.117</td></tr><tr><td>19.</td><td>Is practical training well organized?</td><td>−.113</td><td>.794</td><td>−.052</td></tr><tr><td>13.</td><td>Did you understand the instructions of the teacher?</td><td>.083</td>... |
7f07e0b76488300bf312b091d9c4513acd6df3129e7a9bb22d366fa2116537db.png | simple | <table><tr><td>Characteristic</td><td>%</td></tr><tr><td>Males</td><td>67.3</td></tr><tr><td>Age, median (range)</td><td>40 (21–79)</td></tr><tr><td>Education level*</td><td> </td></tr><tr><td> Less than high school</td><td>31.4</td></tr><tr><td> High school</td><td>39.2</td></tr><tr><td> College</td><td>29.4</td... | <table><tr><td>Characteristic</td><td>%</td></tr><tr><td>Males</td><td>67.3</td></tr><tr><td>Age, median (range)</td><td>40 (21–79)</td></tr></table> | <table><tr><td>Characteristic</td><td>%</td></tr><tr><td>Education level*</td><td></td></tr><tr><td>Less than high school</td><td>31.4</td></tr><tr><td>High school</td><td>39.2</td></tr><tr><td>College</td><td>29.4</td></tr><tr><td>Employment status*</td><td></td></tr><tr><td>Employed</td><td>25.0</td></tr><tr><td>Unem... |
184b2d6c9d0bf5e91f1789954411cbf48a2c311d8b8ca9e039a1d45d57796ed4.png | simple | <table><tr><td>Variable</td><td>No</td><td>ΔCt (Mean ± SD)</td><td> </td></tr><tr><td> </td><td> </td><td><i>SAA1</i></td><td><i>SAA4</i></td></tr><tr><td>NNL tissues</td><td>10</td><td>7.64 ± 2.02</td><td>13.63 ± 3.11</td></tr><tr><td>CC tissues</td><td>21</td><td>2.85 ± 3.02</td><td>9.12 ... | <table><tr><td>Variable</td><td>No</td><td>ΔCt (Mean ± SD)</td><td></td></tr><tr><td></td><td></td><td>SAA1</td><td>SAA4</td></tr></table> | <table><tr><td>Variable</td><td>No</td><td>ΔCt (Mean ± SD)</td><td></td></tr><tr><td>NNL tissues</td><td>10</td><td>7.64 ± 2.02</td><td>13.63 ± 3.11</td></tr><tr><td>CC tissues</td><td>21</td><td>2.85 ± 3.02</td><td>9.12 ± 3.05</td></tr><tr><td>ΔΔCt</td><td></td><td>4.79 (P < 0.000)</td><td>4.51 (P = 0.001)</td></tr><t... |
7a1c550ea543817d3200b08ba1e3a909fcc426e952956bd17949029b13c61e05.png | simple | <table><tr><td>Gene Set</td><td>Number of Genes in Original Set</td><td>Number of Genes Present in GWAS Data</td><td>Number of SNPs Present in GWAS Data</td><td>Self-Contained <i>p</i>-Value (α = 2.8 × 10<sup>−3</sup>)</td><td>Competitive <i>p</i>-Value (α = 0.05)</td></tr><tr><td>All synaptic gene... | <table><tr><td>Gene Set</td><td>Number of Genes in Original Set</td><td>Number of Genes Present in GWAS Data</td><td>Number of SNPs Present in GWAS Data</td><td>Self-Contained p-Value (α = 2.8 × 10−3)</td><td>Competitive p-Value (α = 0.05)</td></tr><tr><td>All synaptic genes</td><td>1028</td><td>956</td><td>61413</td><... | <table><tr><td>Endocytosis</td><td>26</td><td>26</td><td>1075</td><td>0.0554</td><td>NA</td></tr><tr><td>Cell adhesion and trans-synaptic signaling</td><td>81</td><td>76</td><td>13550</td><td>0.0709</td><td>NA</td></tr><tr><td>Exocytosis</td><td>87</td><td>83</td><td>4855</td><td>0.0962</td><td>NA</td></tr><tr><td>Prot... |
5db4f6440c128418861e709c350c5c1eed364266813d7a5682d3842af46d8c09.png | complex | <table><tr><td>Perdriolle degree difference</td><td colspan="3">JIS (R2 = 0.40)</td><td colspan="3">AIS (R2 = 0.29)</td></tr><tr><td>Independent variables</td><td>B coefficient</td><td>Standard error</td><td>p</td><td>B coefficient</td><td>Standard error</td><td>p</td></tr><tr><td> </td><td>Complete (reference)</td><td... | <table><tr><td>Perdriolle degree difference</td><td colspan="3">JIS (R2 = 0.40)</td><td colspan="3">AIS (R2 = 0.29)</td></tr><tr><td>Independent variables</td><td>B coefficient</td><td>Standard error</td><td>p</td><td>B coefficient</td><td>Standard error</td><td>p</td></tr><tr><td></td><td>Complete (reference)</td><td>... | <table><tr><td>Perdriolle degree difference</td><td colspan="3">JIS (R2 = 0.40)</td><td colspan="3">AIS (R2 = 0.29)</td></tr><tr><td>Independent variables</td><td>B coefficient</td><td>Standard error</td><td>p</td><td>B coefficient</td><td>Standard error</td><td>p</td></tr><tr><td rowspan="4">Adherence</td><td>Incomple... |
103b49cab448bb85a664ab108b418d52de8d5fc30c3576a911066de057ca1849.png | simple | <table><tr><td>Disease</td><td>Underlying Disease(s)</td><td>Incidence/Prevalence Used to Estimate Burden</td><td>Comments</td><td>Reference</td></tr><tr><td>Oesophageal candidiasis</td><td>HIV/AIDS</td><td>22% of patients with CD4 counts <200 × 10<sup>6</sup>/mL and 5% of ARV-treated patients</td><td></td><td>... | <table><tr><td>Disease</td><td>Underlying Disease(s)</td><td>Incidence/Prevalence Used to Estimate Burden</td><td>Comments</td><td>Reference</td></tr><tr><td>Oesophageal candidiasis</td><td>HIV/AIDS</td><td>22% of patients with CD4 counts <200 × 106/mL and 5% of ARV-treated patients</td><td></td><td>[17]</td></tr><tr><... | <table><tr><td>hma with fungal sensitisation</td><td>thma</td><td> of the 10% of the most severe adult asthmatics</td><td>Fungal sensitization prevalence not known for Cameroon.</td><td>22]</td></tr><tr><td>Chronic pulmonary aspergillosis</td><td>Tuberculosis (TB), COPD, prior pneumothorax, asthma, lung surgery</td><td... |
2815091e6010b4e1a0dfe7cf972505b0a5aaca1fbfb6f4adaefd2b763a720d1c.png | complex | <table><tr><td rowspan="3">Subject number</td><td rowspan="3">Age</td><td rowspan="3">Gender</td><td colspan="2">BCVA</td><td colspan="2">IOP (mmHg)</td><td colspan="4">C/D</td><td colspan="2">VF</td></tr><tr><td rowspan="2">RE</td><td rowspan="2">LE</td><td rowspan="2">RE</td><td rowspan="2">LE</td><td colspan="2">RE<... | <table><tr><td rowspan="3">Subject number</td><td rowspan="3">Age</td><td rowspan="3">Gender</td><td colspan="2">BCVA</td><td colspan="2">IOP (mmHg)</td><td colspan="4">C/D</td><td colspan="2">VF</td></tr><tr><td rowspan="2">RE</td><td rowspan="2">LE</td><td rowspan="2">RE</td><td rowspan="2">LE</td><td colspan="2">RE<... | <table><tr><td>I1</td><td></td><td>F</td><td>4</td><td>0.7</td><td>6.3</td><td>13.7</td><td></td><td>0.8</td><td>.9</td><td></td><td>N/A</td><td>A</td></tr><tr><td>III4</td><td>48</td><td>F</td><td>1.5</td><td>1.2</td><td>27.3</td><td>23</td><td>0.5</td><td>0.5</td><td>0.7</td><td>0.7</td><td>N</td><td>N</td></tr><tr><... |
73717041be39e646bef7e3248f143d0efbe23ba4bcf9d34f8ca7b77085c279fe.png | complex | <table><tr><td rowspan="2"> Tissue</td><td colspan="4">Concentration (μg g<sup>–1</sup> fresh weight of tissue)</td></tr><tr><td>(–)-Kolavenol</td><td>Hardwickiic acid</td><td>Salvinorin B</td><td>Salvinorin A</td></tr><tr><td>Leaf</td><td>0.200 ± 0.031</td><td>2.00 ± 0.27</td><td>31.0 ±... | <table><tr><td>Tissue</td><td colspan="4">Concentration (μg g–1 fresh weight of tissue)</td></tr></table> | <table><tr><td>Tissue</td><td>(–)-Kolavenol</td><td>Hardwickiic acid</td><td>Salvinorin B</td><td>Salvinorin A</td></tr><tr><td>Leaf</td><td>0.200 ± 0.031</td><td>2.00 ± 0.27</td><td>31.0 ± 1.6</td><td>30.0 ± 2.3</td></tr><tr><td>Gland</td><td>1100 ± 170</td><td>15 000 ± 1100</td><td>150 000 ± 24 000</td><td>250 000 ± ... |
82bbbd19a0790ab0c1a988d76c3ddfbb7fe24cf156fe4f2959ac592c5ee4d550.png | simple | <table><tr><td>Ideas for better cooperation</td><td>examples</td></tr><tr><td>Mutual accessibility</td><td>• use of faxes: obligatory processes, standardised forms, notation on urgency• establish telephone consulting hours for the GP• acute telephone calls: availability of mobile number of GP• c... | <table><tr><td>Ideas for better cooperation</td><td>examples</td></tr><tr><td>Mutual accessibility</td><td>• use of faxes: obligatory processes, standardised forms, notation on urgency• establish telephone consulting hours for the GP• acute telephone calls: availability of mobile number of GP• contact nurse in the nurs... | <table><tr><td>Appreciation and respect</td><td>• mutual respect, trust, tolerance of mistakes• establishment of a communication culture• acknowledgement of nurse /GP competencies (feedback, enough time, listening, GP asks for suggestions from nurses)• to be on equal level, provision of patient care in partnership</td>... |
ec05057c817d938500ca2dba08685ad2268e225ab776c2300dee5908ac9079a6.png | complex | <table><tr><td> </td><td> </td><td colspan="2">Mean mitocondrial area (μm<sup>2</sup>)</td></tr><tr><td>Genotype</td><td>Treatment</td><td>Myelinated</td><td>Unmyelinated</td></tr><tr><td rowspan="3">WT</td><td>Naive</td><td>0.102 ± 0.002</td><td>0.135 ± 0.016<sup>#</sup></td></tr><tr><td>Vehicle</td><td... | <table><tr><td></td><td></td></tr><tr><td>Genotype</td><td>Treatment</td></tr><tr><td rowspan="3">WT</td><td>Naive</td></tr><tr><td>Vehicle</td></tr><tr><td>Paclitaxel</td></tr><tr><td rowspan="3">σ1R-KO</td><td>Naive</td></tr><tr><td>Vehicle</td></tr><tr><td>Paclitaxel</td></tr></table> | <table><tr><td colspan="2">Mean mitocondrial area (μm2)</td></tr><tr><td>Myelinated</td><td>Unmyelinated</td></tr><tr><td>0.102 ± 0.002</td><td>0.135 ± 0.016#</td></tr><tr><td>0.117 ± 0.008</td><td>0.164 ± 0.006##</td></tr><tr><td>0.134 ± 0.007**</td><td>0.161 ± 0.009#</td></tr><tr><td>0.107 ± 0.005</td><td>0.134 ± 0.0... |
464bb7993cc53d00d3dfac90201c0e2ed2cb3dbe3450fde9fa352b26dd128953.png | complex | <table><tr><td></td><td>Pregnant women (weeks' gestation)</td><td>Postpartum women (months postpartum)</td></tr><tr><td colspan="3"><i>Questionnaires for the participants</i></td></tr><tr><td>Background, physical activity, diet, psychosocial wellbeing</td><td>8–9</td><td>2</td></tr><tr><td>Physical activity, feed... | <table><tr><td></td><td>Pregnant women (weeks' gestation)</td><td>Postpartum women (months postpartum)</td></tr><tr><td colspan="3">Questionnaires for the participants</td></tr><tr><td>Background, physical activity, diet, psychosocial wellbeing</td><td>8–9</td><td>2</td></tr><tr><td>Physical activity, feedback for phys... | <table><tr><td></td><td>Pregnant women (weeks' gestation)</td><td>Postpartum women (months postpartum)</td></tr><tr><td>Adverse events form</td><td>16–18, 22–24, 32–34 and 36–37</td><td>3, 5, 6 and 10</td></tr><tr><td>A copy of the maternity card (weight development and other data on pregnancy)</td><td>after delivery</... |
43296047448c2bfa881d902a22ffeff346a0a0d64dfc7c171c671a2e1b452e04.png | complex | <table><tr><td colspan="5">MSigDB pathway</td><td></td><td></td><td colspan="2">C26 (Fold change)</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>Gene description</td><td>Gene symbol</td><td>AAV9-ev</td><td>AAV9-dnFoxO*</td></tr><tr><td>x</td><td>x</td><td>x</td><td>x</td><td>x</td><td>collagen, type... | <table><tr><td colspan="5">MSigDB pathway</td><td></td><td></td><td colspan="2">C26 (Fold change)</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>Gene description</td><td>Gene symbol</td><td>AAV9-ev</td><td>AAV9-dnFoxO*</td></tr><tr><td>x</td><td>x</td><td>x</td><td>x</td><td>x</td><td>collagen, type... | <table><tr><td colspan="5">MSigDB pathway</td><td></td><td></td><td colspan="2">C26 (Fold change)</td></tr><tr><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>Gene description</td><td>Gene symbol</td><td>AAV9-ev</td><td>AAV9-dnFoxO*</td></tr><tr><td>x</td><td>x</td><td>x</td><td>x</td><td>x</td><td>collagen, type... |
4a5624dae8ed9e18c68f1c1417a8a7557d58b3252e56b6fcd427cb37e50d467e.png | simple | <table><tr><td>Project</td><td>Number of participants interviewed</td></tr><tr><td>Total non-Indigenous participants</td><td>28 (19 F, 9 M)</td></tr><tr><td>Total Indigenous research participants</td><td>8 (6 F, 2 M)</td></tr><tr><td>TOTAL research participants</td><td>36 (24 F, 11 M)</td></tr></table> | <table><tr><td>Project</td><td>Number of participants interviewed</td></tr></table> | <table><tr><td>Total non-Indigenous participants</td><td>28 (19 F, 9 M)</td></tr><tr><td>Total Indigenous research participants</td><td>8 (6 F, 2 M)</td></tr><tr><td>TOTAL research participants</td><td>36 (24 F, 11 M)</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.